var title_f18_38_19040="Salmon patch";
var content_f18_38_19040=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F70234&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F70234&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Nevus simplex (also called \"salmon patch\" or \"stork bite\")",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 324px; height: 223px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This splotchy pink mark fades with age.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Fletcher, M. Physical Diagnosis in Neonatology. Lippincott-Raven Publishers, Philadelphia 1998. Copyright &copy;1998 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_38_19040=[""].join("\n");
var outline_f18_38_19040=null;
var title_f18_38_19041="Patterns of airflow";
var content_f18_38_19041=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F63878&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F63878&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Patterns of airflow",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 310px; height: 467px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A represents laminar flow; B shows turbulent flow, and C demonstrates transition flow at a bifurcation. EL is the entrance length, the distance required to re-establish laminar flow.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_38_19041=[""].join("\n");
var outline_f18_38_19041=null;
var title_f18_38_19042="Nuclear cataract 2";
var content_f18_38_19042=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F80566&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F80566&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Nuclear cataract",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 286px; height: 396px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Nuclear cataract of congenital rubella syndrome.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Gold DH, MD, and Weingeist TA, MD, PhD. Color Atlas of the Eye in Systemic Disease. Baltimore: Lippincott Williams &amp; Wilkins, 2001. Copyright &copy; 2001 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_38_19042=[""].join("\n");
var outline_f18_38_19042=null;
var title_f18_38_19043="Hypokalemia tutorial";
var content_f18_38_19043=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F73888&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F73888&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 519px\">",
"   <div class=\"ttl\">",
"    Hypokalemia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 499px; height: 108px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    An increase in the amplitude of U waves, which occur at the end of the T wave, are characteristic of hypokalemia.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_38_19043=[""].join("\n");
var outline_f18_38_19043=null;
var title_f18_38_19044="Approach to metabolic myopathy";
var content_f18_38_19044=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F71018&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F71018&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 595px\">",
"   <div class=\"ttl\">",
"    Algorithm for the diagnosis of metabolic myopathies",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 575px; height: 638px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In a patient with signs that raise the possibility of a metabolic myopathy, the constellation of clinical and laboratory features and the type of exercise inducing the symptoms may indicate the nature of the underlying biochemical defect and thus narrow down the laboratory investigation.",
"    <div class=\"footnotes\">",
"     CNS: central nervous system; PNS: peripheral nervous system.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Darras BT, Friedman NR. Metabolic myopathies: A clinical approach, Part I. Pediatr Neurol 2000; 22:87. Copyright &copy; 2000 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_38_19044=[""].join("\n");
var outline_f18_38_19044=null;
var title_f18_38_19045="Ankylosing spondylitis and spondyloarthritis";
var content_f18_38_19045=[" <h1 id=\"patTopicTitle\">",
"  Patient information: Ankylosing spondylitis and spondyloarthritis (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?18/38/19045/contributors\">",
"       Author",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/38/19045/contributors\" id=\"au6352\">",
"       David T Yu, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?18/38/19045/contributors\">",
"       Section Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/38/19045/contributors\" id=\"se174\">",
"       Joachim Sieper, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?18/38/19045/contributors\">",
"       Deputy Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/38/19045/contributors\" id=\"de4792\">",
"       Jerry M Greene, MD",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"UTD.htm?18/38/19045?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      ANKYLOSING SPONDYLITIS OVERVIEW",
"     </span>",
"    </p>",
"    <p>",
"     Ankylosing spondylitis (AS) is a chronic inflammatory disease that causes pain in the back, the neck, and, sometimes, the hips. The back is composed of multiple separate bones known as vertebrae. &ldquo;Ankylosing&rdquo; means joining together and refers to an inflexibility between the vertebrae. &ldquo;Spondylitis&rdquo; means inflammation of the vertebrae. Spondyloarthritis refers to a group of diseases that share a tendency to cause spondylitis, some of which also cause inflammation of other joints besides those of the spine.",
"    </p>",
"    <p>",
"     This topic discusses the symptoms, diagnostic tests, possible complications, and treatment of one of the family of spondyloarthritis diseases, ankylosing spondylitis. It also discusses some of the diseases that are classified as subtypes of spondyloarthritis. Separate topic reviews are available that discuss some of the medications used to treat ankylosing spondylitis and exercises that can help people with ankylosing spondylitis with stretching and strengthening. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?26/40/27266?source=see_link\">",
"      \"Patient information: Disease-modifying antirheumatic drugs (DMARDs) (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?27/62/28645?source=see_link\">",
"      \"Patient information: Arthritis and exercise (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H12021556\">",
"     <span class=\"h1\">",
"      SPONDYLOARTHRITIS FAMILY OF ARTHRITIS",
"     </span>",
"    </p>",
"    <p>",
"     Spondyloarthritis is a family of arthritis, of which ankylosing spondylitis is the most common member. The other members are:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Undifferentiated spondyloarthritis",
"      </li>",
"      <li>",
"       Non-radiographic axial spondyloarthritis",
"      </li>",
"      <li>",
"       Reactive arthritis",
"      </li>",
"      <li>",
"       Arthritis associated with psoriasis (psoriatic arthritis)",
"      </li>",
"      <li>",
"       Arthritis associated with inflammatory bowel diseases (ulcerative colitis or Crohn&rsquo;s disease)",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     Spondyloarthritis has also been classified into &ldquo;axial&rdquo; and &ldquo;peripheral&rdquo; spondyloarthritis according to whether the involvement is mainly in the spine or in the extremities. Ankylosing spondylitis belongs to the axial class of spondyloarthritis. Many patients diagnosed as having an axial form of undifferentiated spondyloarthritis may subsequently develop ankylosing spondylitis. Separate topic reviews discuss reactive arthritis, psoriatic arthritis, and inflammatory bowel diseases. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?30/0/30721?source=see_link\">",
"      \"Patient information: Reactive arthritis (formerly Reiter syndrome) (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?35/36/36419?source=see_link\">",
"      \"Patient information: Psoriatic arthritis (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?10/39/10869?source=see_link\">",
"      \"Patient information: Ulcerative colitis (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?23/40/24196?source=see_link\">",
"      \"Patient information: Crohn's disease (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      ANKYLOSING SPONDYLITIS SYMPTOMS",
"     </span>",
"    </p>",
"    <p>",
"     The most common symptom of ankylosing spondylitis is pain in the lower back. Pain, stiffness, and limited mobility in other joints also occur in some patients. More detailed information is available separately. (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/9/151?source=see_link\">",
"      \"Clinical manifestations of ankylosing spondylitis in adults\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H3\">",
"     <span class=\"h2\">",
"      Spinal pain",
"     </span>",
"     &nbsp;&mdash;&nbsp;Spinal pain, almost always in the lower back, is usually the first and most common symptom of ankylosing spondylitis. Back pain that occurs with ankylosing spondylitis generally has some of the following characteristics:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Begins in early adulthood (before 45 years of age)",
"      </li>",
"      <li>",
"       Has gradual onset (rather than sudden onset after an acute injury)",
"      </li>",
"      <li>",
"       Lasts longer than three months",
"      </li>",
"      <li>",
"       Is worse after rest (for example, in the morning)",
"      </li>",
"      <li>",
"       Improves with activity",
"      </li>",
"      <li>",
"       Wakes you up in the second half of the night",
"      </li>",
"      <li>",
"       Can cause morning stiffness lasting more than 30 minutes",
"      </li>",
"      <li>",
"       Can cause buttock pain that alternates between the left and right side",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H4\">",
"     <span class=\"h2\">",
"      Limited spinal mobility",
"     </span>",
"     &nbsp;&mdash;&nbsp;The flexibility of the back may be reduced. Putting on shoes and stockings may become difficult due to a limited ability to bend forward.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H5\">",
"     <span class=\"h2\">",
"      Other symptoms",
"     </span>",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Hip pain &mdash; Arthritis of the hips is relatively common in ankylosing spondylitis, causing pain in the groin or buttocks or difficulty walking.",
"      </li>",
"      <li>",
"       Shoulder pain &mdash; Inflammation of the tendon and bone may cause shoulder pain and limited mobility of the affected shoulder(s).",
"      </li>",
"      <li>",
"       Arthritis in other joints &mdash; Pain, stiffness, and swelling of other joints may occur. A single joint (monoarthritis) or a few joints (oligoarthritis) may be affected.",
"      </li>",
"      <li>",
"       Enthesitis &mdash; An enthesis is a region in which a tendon or a ligament attaches to bone. Enthesitis (inflammation of an enthesis) is a symptom of spondyloarthritis. In addition to the spine, a major area of symptomatic enthesitis is at the heel.",
"      </li>",
"      <li>",
"       Constitutional features &mdash; As with any chronic inflammatory disease, people with ankylosing spondylitis may be tired and may feel unwell. Difficulty sleeping, caused by back or joint pain at night, may contribute to fatigue. Low-grade fevers and weight loss occur in some patients.",
"      </li>",
"      <li>",
"       Other affected systems &mdash; Body systems other than the joints can be affected. (See",
"       <a class=\"local\" href=\"#H10\">",
"        'Ankylosing spondylitis complications'",
"       </a>",
"       below.)",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H6\">",
"     <span class=\"h1\">",
"      ANKYLOSING SPONDYLITIS RISK FACTORS",
"     </span>",
"    </p>",
"    <p>",
"     Ankylosing spondylitis is three times more common in males than in females. It is usually diagnosed in young adults between the ages of 20 and 30 years.",
"    </p>",
"    <p>",
"     The disease can be more common in certain families. For example, a person's risk of developing ankylosing spondylitis increases if a first-degree relative (parent, sibling, or child) has ankylosing spondylitis. The presence of a gene called HLA-B27 may also increase the risk of developing ankylosing spondylitis.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H7\">",
"     <span class=\"h1\">",
"      ANKYLOSING SPONDYLITIS DIAGNOSIS",
"     </span>",
"    </p>",
"    <p>",
"     The diagnosis of ankylosing spondylitis is based upon a combination of a patient's symptoms, physical examination, and imaging tests. (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/20/13640?source=see_link\">",
"      \"Diagnosis and differential diagnosis of ankylosing spondylitis in adults\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H8\">",
"     <span class=\"h2\">",
"      Imaging tests",
"     </span>",
"     &nbsp;&mdash;&nbsp;People with ankylosing spondylitis develop characteristic changes in the sacroiliac joints (the joint that connects the base of the spine [sacrum] and large pelvic bone [ilium]). These changes can be seen on x-ray images, although the changes take time to develop and may not be apparent until years after ankylosing spondylitis is diagnosed.",
"    </p>",
"    <p>",
"     Imaging tests such as magnetic resonance imaging (MRI) are more sensitive than plain x-rays and may be used if ankylosing spondylitis is suspected but is not clearly seen on x-ray.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H9\">",
"     <span class=\"h2\">",
"      Other tests",
"     </span>",
"     &nbsp;&mdash;&nbsp;There is no blood test that, by itself, is capable of definitively diagnosing or excluding ankylosing spondylitis. However, testing for a particular type of gene, HLA-B27, can be helpful in selected groups of patients. Ankylosing spondylitis is unlikely in a patient with a negative test for HLA-B27 who is white and of European descent. Ankylosing spondylitis is even less likely if x-rays and MRI are normal or show no changes to suggest ankylosis of the sacroiliac joint or inflammation in that area.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H10\">",
"     <span class=\"h1\">",
"      ANKYLOSING SPONDYLITIS COMPLICATIONS",
"     </span>",
"    </p>",
"    <p>",
"     Complications of ankylosing spondylitis are uncommon, with the exception of anterior uveitis.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H11\">",
"     <span class=\"h2\">",
"      Anterior uveitis",
"     </span>",
"     &nbsp;&mdash;&nbsp;Uveitis, or inflammation of part of the eye, is the most common ankylosing spondylitis-related problem that does not involve joints. Uveitis causes pain in the eye, blurring of vision, and light sensitivity. Uveitis requires immediate medical attention and treatment with eye medications but often resolves within several months.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H3934298\">",
"     <span class=\"h2\">",
"      Spinal fractures and spinal cord injuries",
"     </span>",
"     &nbsp;&mdash;&nbsp;Spinal fractures and spinal cord injuries are 4 and 11 times more common in patients with ankylosing spondylitis than in the general population. Most of the acute fractures occur in the neck. The preceding injuries might be trivial and of low impact. Patients with spinal cord injuries may have only minor initial neurological symptoms. Any neck or spine injury requires immobilization, consultation with a doctor, and evaluation in an emergency facility. More than half of neck fractures in patients with ankylosing spondylitis are undetectable by plain x-ray. Computed tomography and MRI are more sensitive imaging techniques.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H12\">",
"     <span class=\"h2\">",
"      Neurologic problems",
"     </span>",
"     &nbsp;&mdash;&nbsp;Cauda equina syndrome is a rare complication that occurs in people with longstanding disease who have severe stiffening of the spine. The symptoms result from damage to many nerves in the lower back and include abnormal sensation, weakness, and difficulty with bladder and bowel control. Men may experience erectile dysfunction or impotence.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H13\">",
"     <span class=\"h2\">",
"      Cardiovascular disease",
"     </span>",
"     &nbsp;&mdash;&nbsp;The most serious problem is a leaking aortic valve (aortic regurgitation) which can cause symptoms of heart failure, including leg or ankle swelling (edema) and shortness of breath during exercise or exertion. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?33/5/33877?source=see_link\">",
"      \"Patient information: Heart failure (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H14\">",
"     <span class=\"h2\">",
"      Pulmonary disease",
"     </span>",
"     &nbsp;&mdash;&nbsp;Many people with ankylosing spondylitis are unable to expand the chest normally during breathing because of stiffness between the ribs and the spine. In some cases, changes in the lungs can result. This may or may not cause breathing problems.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H15\">",
"     <span class=\"h2\">",
"      Ulcerations in the bowel",
"     </span>",
"     &nbsp;&mdash;&nbsp;Some people with ankylosing spondylitis will develop ulcerations in the lining of the bowels, although these ulcerations do not usually cause any symptoms.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H16\">",
"     <span class=\"h1\">",
"      EFFECTS OF ANKYLOSING SPONDYLITIS ON DAILY LIFE",
"     </span>",
"    </p>",
"    <p>",
"     Ankylosing spondylitis can affect daily life in various ways. Dressing, reaching, rising from a chair, getting up from the floor, standing, climbing steps, looking to the side or over the shoulder, exercising, and doing household or work-related tasks can become more difficult as a result of the limited joint and spinal motion in ankylosing spondylitis. These limitations can affect you and your family, and many people with ankylosing spondylitis will require assistance from family and friends.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H17\">",
"     <span class=\"h1\">",
"      ANKYLOSING SPONDYLITIS TREATMENT",
"     </span>",
"    </p>",
"    <p>",
"     Ankylosing spondylitis treatment is tailored for each individual, based on the characteristics and severity of the disease. Treatment may include any of the following (see",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/23/35194?source=see_link\">",
"      \"Assessment and treatment of ankylosing spondylitis in adults\"",
"     </a>",
"     ):",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H18\">",
"     <span class=\"h2\">",
"      Exercise",
"     </span>",
"     &nbsp;&mdash;&nbsp;Exercise should be part of the treatment program for everyone with ankylosing spondylitis. It can include home exercises, individual or group exercise with a physical therapist, or physical therapy (PT) treatments. Optimally, each patient should be evaluated and given instructions by a physical therapist. The exercise should consist of posture training, deep breathing, back extension, and other stretching movements. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?27/62/28645?source=see_link\">",
"      \"Patient information: Arthritis and exercise (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     Information about exercises designed for people with ankylosing spondylitis is available on the following website:",
"     <a class=\"external\" href=\"file://www.nass.co.uk/exercise/\">",
"      www.nass.co.uk/exercise/",
"     </a>",
"     .",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H289015719\">",
"     <span class=\"h2\">",
"      Safety issues",
"     </span>",
"     &nbsp;&mdash;&nbsp;Because of the increased risk of serious spinal injury from slips and falls, people with ankylosing spondylitis should take care to avoid such mishaps. Some simple measures include limiting the use of alcohol. Pain relieving drugs (such as codeine and other narcotics) and sedatives (sleeping pills) should also be used cautiously, if at all, since these also increase the risk of falling. Contact sports and other high-impact activities should be avoided.",
"    </p>",
"    <p>",
"     Shower or tub grab-bars and night-lights decrease the chance of a fall. Loose rugs increase the risk of tripping and should be removed or carefully attached to the floor with removable adhesive strips or pads. Seat belts reduce the risk of injury in a car crash and should be worn while driving or riding in a vehicle. A wrap-around rear view mirror can improve visibility for drivers who cannot turn their head and neck.",
"    </p>",
"    <p>",
"     To avoid developing deformities of the neck, a thin, rather than a thick, pillow is recommended for sleeping.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H19\">",
"     <span class=\"h2\">",
"      Medications",
"     </span>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H20\">",
"     <span class=\"h3\">",
"      Nonsteroidal antiinflammatory drugs (NSAID)",
"     </span>",
"     &nbsp;&mdash;&nbsp;An NSAID is commonly used to control pain and stiffness. NSAIDs need to be taken on a regular basis for several weeks before their maximum effect can be judged. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?2/13/2262?source=see_link\">",
"      \"Patient information: Nonsteroidal antiinflammatory drugs (NSAIDs) (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H21\">",
"     <span class=\"h3\">",
"      Sulfasalazine",
"     </span>",
"     &nbsp;&mdash;&nbsp;Sulfasalazine is a disease modifying antirheumatic drug, or DMARD, that may be given to slow or stop the progression of ankylosing spondylitis. It may be given along with NSAIDs. This drug provides some relief of arthritis symptoms but is not helpful if ankylosing spondylitis only affects the spine. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?26/40/27266?source=see_link\">",
"      \"Patient information: Disease-modifying antirheumatic drugs (DMARDs) (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?17/11/17586?source=see_link\">",
"      \"Patient information: Sulfasalazine and the 5-aminosalicylates (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H22\">",
"     <span class=\"h3\">",
"      Anti-tumor necrosis factor therapy",
"     </span>",
"     &nbsp;&mdash;&nbsp;A group of medicines known as anti-tumor necrosis factor agents (anti-TNF) or TNF inhibitors is often effective in the treatment of ankylosing spondylitis. Examples of anti-TNF medications include infliximab, etanercept, adalimumab, certolizumab pegol, and golimumab. People who do not respond to one anti-TNF treatment may respond to another. Improvement in symptoms is common and may occur within a few weeks of starting the drugs. However, these drugs may not be very effective in stopping the progression of the disease.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Who should use anti-TNF therapy? &mdash; Not every patient with ankylosing spondylitis needs anti-TNF therapy. In general, people with active disease in the spine who have not responded fully to NSAIDs may be candidates. The decision to use anti-TNF therapy depends upon several factors that should be discussed with your clinician.",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     Some clinicians may also recommend a glucocorticoid injection into particularly painful or swollen joints, especially if there is only one or a two that are causing the most pain. (See",
"     <a class=\"local\" href=\"#H23\">",
"      'Glucocorticoids (steroids)'",
"     </a>",
"     below.)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H23\">",
"     <span class=\"h3\">",
"      Glucocorticoids (steroids)",
"     </span>",
"     &nbsp;&mdash;&nbsp;In some cases, a glucocorticoid injection into the sacroiliac joint may help provide relief in patients who have sacroiliac pain that has not responded to other therapies.",
"    </p>",
"    <p>",
"     In contrast, taking glucocorticoids by mouth is rarely necessary in ankylosing spondylitis treatment.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H24\">",
"     <span class=\"h2\">",
"      Surgery",
"     </span>",
"     &nbsp;&mdash;&nbsp;Hip or spine surgery may be beneficial in selected patients with ankylosing spondylitis. Surgical procedures may include one or more of the following:",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H25\">",
"     <span class=\"h3\">",
"      Total hip replacement",
"     </span>",
"     &nbsp;&mdash;&nbsp;Insertion of an artificial hip may be recommended in patients with ankylosing spondylitis who have severe, persistent hip pain or severely limited mobility due to hip joint arthritis. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?21/30/21987?source=see_link\">",
"      \"Patient information: Total hip replacement (arthroplasty) (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H26\">",
"     <span class=\"h3\">",
"      Spinal surgery",
"     </span>",
"     &nbsp;&mdash;&nbsp;Fusion of the bones in the cervical spine may be recommended for a small number of patients who develop dislocation of these bones. Such surgery may help prevent spinal cord damage.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H27\">",
"     <span class=\"h3\">",
"      Wedge osteotomy",
"     </span>",
"     &nbsp;&mdash;&nbsp;Wedge osteotomy involves the removal of a wedge-shaped piece of bone from a vertebra, followed by realignment of the spine. The spine is then braced and is allowed to heal in a better position. This type of procedure may be recommended for people who develop severe deformities of the neck.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H28\">",
"     <span class=\"h1\">",
"      PREVENTING ANKYLOSING SPONDYLITIS COMPLICATIONS",
"     </span>",
"    </p>",
"    <p>",
"     Because the severity and outcome of ankylosing spondylitis vary considerably among patients, treatment must be tailored to each particular patient. However, all patients can benefit from the following:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Stop smoking cigarettes. People who smoke and have ankylosing spondylitis can have problems with their breathing. Ankylosing spondylitis can limit the movement of the chest and can reduce the amount of air the lungs can hold. (See",
"       <a class=\"medical medical_patient\" href=\"UTD.htm?19/13/19670?source=see_link\">",
"        \"Patient information: Quitting smoking (Beyond the Basics)\"",
"       </a>",
"       .)",
"      </li>",
"      <li>",
"       Maintain correct posture, and participate in an exercise program. (See",
"       <a class=\"medical medical_patient\" href=\"UTD.htm?27/62/28645?source=see_link\">",
"        \"Patient information: Arthritis and exercise (Beyond the Basics)\"",
"       </a>",
"       .)",
"      </li>",
"      <li>",
"       Consume an adequate amount of calcium and vitamin D in order to reduce the risk of bone loss (osteoporosis). Products that contain calcium and vitamin D include dairy products like milk, cheese, and yogurt or non-prescription calcium and vitamin D supplements. (See",
"       <a class=\"medical medical_patient\" href=\"UTD.htm?22/60/23491?source=see_link\">",
"        \"Patient information: Calcium and vitamin D for bone health (Beyond the Basics)\"",
"       </a>",
"       .)",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     Medications that treat bone loss may be recommended if you have already lost bone strength. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?1/29/1491?source=see_link\">",
"      \"Patient information: Bone density testing (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?24/49/25366?source=see_link\">",
"      \"Patient information: Osteoporosis prevention and treatment (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H12021571\">",
"     <span class=\"h1\">",
"      UNDIFFERENTIATED SPONDYLOARTHRITIS",
"     </span>",
"    </p>",
"    <p>",
"     Someone who has spondyloarthritis but who does not have sufficient features to be diagnosed as having ankylosing spondylitis, reactive arthritis, arthritis associated with psoriasis, ulcerative colitis, or Crohn&rsquo;s disease may be diagnosed as having undifferentiated spondyloarthritis.",
"     <strong>",
"     </strong>",
"     The major involvement might be the spine, the extremities, or both. The approach by the doctors toward diagnosis and treatment are similar to those of ankylosing spondylitis listed above. &nbsp;(See",
"     <a class=\"local\" href=\"#H17\">",
"      'Ankylosing spondylitis treatment'",
"     </a>",
"     above.) If the symptoms are mostly in the spine, the clinician may diagnose it as non-radiographic spondyloarthritis instead of undifferentiated spondyloarthritis.",
"    </p>",
"    <p>",
"     If a diagnosis of undifferentiated spondyloarthritis or non-radiographic spondyloarthritis is made, additional medical visits are necessary, because, with time, one of the more specific types of spondyloarthritis may be diagnosed. However, some patients continue to have undifferentiated spondyloarthritis or non-radiographic spondyloarthritis, and some go into remission and can stop taking medications for pain and stiffness.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H29\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your healthcare provider is the best source of information for questions and concerns related to your medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H864124907\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H21383178\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?8/7/8307?source=see_link\">",
"      Patient information: Ankylosing spondylitis (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?9/22/9571?source=see_link\">",
"      Patient information: Arthritis and exercise (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?29/0/29698?source=see_link\">",
"      Patient information: Reactive arthritis (Reiter syndrome) (The Basics)",
"     </a>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H21383187\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?26/40/27266?source=see_link\">",
"      Patient information: Disease-modifying antirheumatic drugs (DMARDs) (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?27/62/28645?source=see_link\">",
"      Patient information: Arthritis and exercise (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?2/13/2262?source=see_link\">",
"      Patient information: Nonsteroidal antiinflammatory drugs (NSAIDs) (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?17/11/17586?source=see_link\">",
"      Patient information: Sulfasalazine and the 5-aminosalicylates (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?21/30/21987?source=see_link\">",
"      Patient information: Total hip replacement (arthroplasty) (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?19/13/19670?source=see_link\">",
"      Patient information: Quitting smoking (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?22/60/23491?source=see_link\">",
"      Patient information: Calcium and vitamin D for bone health (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?1/29/1491?source=see_link\">",
"      Patient information: Bone density testing (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?24/49/25366?source=see_link\">",
"      Patient information: Osteoporosis prevention and treatment (Beyond the Basics)",
"     </a>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H864124900\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/9/151?source=see_link\">",
"      Clinical manifestations of ankylosing spondylitis in adults",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/20/13640?source=see_link\">",
"      Diagnosis and differential diagnosis of ankylosing spondylitis in adults",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/58/24490?source=see_link\">",
"      Diseases of the chest wall",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/23/17782?source=see_link\">",
"      General guidelines for use of anti-tumor necrosis factor alpha agents in ankylosing spondylitis and axial spondyloarthritis",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/51/12090?source=see_link\">",
"      Pathogenesis of spondyloarthritis",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/23/35194?source=see_link\">",
"      Assessment and treatment of ankylosing spondylitis in adults",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/57/9114?source=see_link\">",
"      Clinical manifestations, diagnosis, and management of undifferentiated spondyloarthritis and related spondyloarthritides",
"     </a>",
"     <br/>",
"     <br/>",
"     The following organizations also provide reliable health information.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Library of Medicine",
"       <br/>",
"       (",
"       <a class=\"external\" href=\"file://www.nlm.nih.gov/medlineplus/healthtopics.html\">",
"        www.nlm.nih.gov/medlineplus/healthtopics.html",
"       </a>",
"       )",
"      </li>",
"      <li>",
"       Spondylitis Association of America",
"       <br/>",
"       (",
"       <a class=\"external\" href=\"file://www.spondylitis.org/\">",
"        www.spondylitis.org",
"       </a>",
"       )",
"      </li>",
"      <li>",
"       Spondyloarthritis Research and Treatment Network",
"       <br/>",
"       (",
"       <a class=\"external\" href=\"file://www.spartangroup.org/\">",
"        www.spartangroup.org",
"       </a>",
"       )",
"      </li>",
"      <li>",
"       National Institute of Arthritis and Musculoskeletal and Skin Diseases",
"       <br/>",
"       (301) 496-8188",
"       <br/>",
"       (",
"       <a class=\"external\" href=\"file://www.nih.gov/niams/\">",
"        www.nih.gov/niams/",
"       </a>",
"       )",
"      </li>",
"      <li>",
"       American College of",
"       <span class=\"nowrap\">",
"        Rheumatology/Association",
"       </span>",
"       of Rheumatology",
"       <br/>",
"       (404) 633-3777",
"       <br/>",
"       (",
"       <a class=\"external\" href=\"file://www.rheumatology.org/\">",
"        www.rheumatology.org",
"       </a>",
"       )",
"      </li>",
"      <li>",
"       The Arthritis Foundation",
"       <br/>",
"       (800) 283-7800",
"       <br/>",
"       (",
"       <a class=\"external\" href=\"file://www.arthritis.org/\">",
"        www.arthritis.org",
"       </a>",
"       )",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     [",
"     <a class=\"abstract\" href=\"UTD.htm?18/38/19045/abstract/1-8\">",
"      1-8",
"     </a>",
"     ]",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 28, 2013.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"UTD.htm?18/38/19045?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <div id=\"patTopicRefHeader\">",
"    <div id=\"patTopicRefHeaderHeader\">",
"     References",
"    </div>",
"    <div id=\"patTopicRefHeaderTop\">",
"     <a href=\"#top\">",
"      <img alt=\"\" src=\"./../images/top_arrow.myextg\">",
"       Top",
"      </img>",
"     </a>",
"    </div>",
"   </div>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19045/abstract/1\">",
"      Dagfinrud H, Kvien TK, Hagen KB. The Cochrane review of physiotherapy interventions for ankylosing spondylitis. J Rheumatol 2005; 32:1899.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19045/abstract/2\">",
"      Brophy S, Mackay K, Al-Saidi A, et al. The natural history of ankylosing spondylitis as defined by radiological progression. J Rheumatol 2002; 29:1236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19045/abstract/3\">",
"      Maugars Y, Mathis C, Berthelot JM, et al. Assessment of the efficacy of sacroiliac corticosteroid injections in spondylarthropathies: a double-blind study. Br J Rheumatol 1996; 35:767.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19045/abstract/4\">",
"      Braun J, Pham T, Sieper J, et al. International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis. Ann Rheum Dis 2003; 62:817.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19045/abstract/5\">",
"      Mau W, Zeidler H, Mau R, et al. Clinical features and prognosis of patients with possible ankylosing spondylitis. Results of a 10-year followup. J Rheumatol 1988; 15:1109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19045/abstract/6\">",
"      Rudwaleit M, van der Heijde D, Landew&eacute; R, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 2009; 68:777.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19045/abstract/7\">",
"      Rudwaleit M, van der Heijde D, Landew&eacute; R, et al. The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 2011; 70:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19045/abstract/8\">",
"      Sampaio-Barros PD, Bortoluzzo AB, Conde RA, et al. Undifferentiated spondyloarthritis: a longterm followup. J Rheumatol 2010; 37:1195.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f18_38_19045=[""].join("\n");
var outline_f18_38_19045=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           ANKYLOSING SPONDYLITIS OVERVIEW",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H12021556\">",
"           SPONDYLOARTHRITIS FAMILY OF ARTHRITIS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H2\">",
"           ANKYLOSING SPONDYLITIS SYMPTOMS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H6\">",
"           ANKYLOSING SPONDYLITIS RISK FACTORS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H7\">",
"           ANKYLOSING SPONDYLITIS DIAGNOSIS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H10\">",
"           ANKYLOSING SPONDYLITIS COMPLICATIONS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H16\">",
"           EFFECTS OF ANKYLOSING SPONDYLITIS ON DAILY LIFE",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H17\">",
"           ANKYLOSING SPONDYLITIS TREATMENT",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H28\">",
"           PREVENTING ANKYLOSING SPONDYLITIS COMPLICATIONS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H12021571\">",
"           UNDIFFERENTIATED SPONDYLOARTHRITIS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H29\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#references\">",
"           REFERENCES",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f18_38_19046="Conglomerate shadows PA I";
var content_f18_38_19046=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F52306&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F52306&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Large opacities in pneumoconiosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 370px; height: 352px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Standard International Labor Office film for large C opacities in patient with either silicosis or coal worker's pneumoconiosis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal chest radiograph",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 371px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Posteroanterior view of a normal chest radiograph.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carol M Black, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_38_19046=[""].join("\n");
var outline_f18_38_19046=null;
var title_f18_38_19047="Male dyspareunia";
var content_f18_38_19047=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Male dyspareunia",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/38/19047/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/38/19047/contributors\">",
"     Mathew Oommen, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/38/19047/contributors\">",
"     Wayne JG Hellstrom, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/38/19047/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/38/19047/contributors\">",
"     Michael P O'Leary, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/38/19047/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/38/19047/contributors\">",
"     Fenny H Lin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?18/38/19047/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 29, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dyspareunia is pain associated with sexual intercourse. This term is most often used in connection with female sexual dysfunction. However, a small subset of the male population also suffers from dyspareunia. Male dyspareunia has been subject to significantly less research compared to its female counterpart.",
"   </p>",
"   <p>",
"    Male dyspareunia is a major life issue for afflicted patients and their partners. The clinician must realize the uncomfortable and often embarrassing nature of this condition. A detailed history and physical examination will lead to proper diagnosis and management.",
"   </p>",
"   <p>",
"    Most studies available on male dyspareunia are small case reports. Few long-term, statistically-significant studies have been published, with the majority of reports focusing on specific associated conditions such as chronic prostatitis or Peyronie's disease. As our understanding of the pathophysiology of male dyspareunia evolves, we anticipate newer diagnostic and treatment methods to become available.",
"   </p>",
"   <p>",
"    This topic will focus on the epidemiology, etiology, classification, diagnosis, and potential therapies for male dyspareunia that are not associated with inflammatory conditions (eg, non-gonococcal urethritis, urinary tract infections, prostatitis, etc). Dyspareunia in women is discussed separately, as is chronic pelvic pain and a general overview of male sexual dysfunction. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/1/43032?source=see_link\">",
"     \"Approach to the woman with sexual pain\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/19/17720?source=see_link\">",
"     \"Chronic prostatitis/chronic pelvic pain syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/44/42696?source=see_link\">",
"     \"Overview of male sexual dysfunction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Due to the social stigma associated with male sexual disorders, underreporting of symptoms is common. It is not known whether the low reported incidence of dyspareunia in males represents a lack of disclosure or reflects the true infrequency of this condition. An increase in open discussion regarding sexuality among men in recent years has resulted in a larger number of men discussing dyspareunia with their primary care clinician. While the exact prevalence of this condition is uncertain, approximately one percent of male patients reported dyspareunia in an older study [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19047/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. A 2008 study sampling over 4000 men in Australia, suggested that 5 percent of men suffer from pain associated with sexual intercourse [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19047/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     ETIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The underlying cause and pathophysiology of pain associated with sexual activity in males cannot be determined in many cases. Male dyspareunia is unlikely to have an infectious etiology.",
"   </p>",
"   <p>",
"    It is possible that proinflammatory cytokines in the genital tract play a role in pain symptoms, similar to the chronic",
"    <span class=\"nowrap\">",
"     prostatitis/chronic",
"    </span>",
"    pelvic pain syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19047/abstract/4\">",
"     4",
"    </a>",
"    ]. However, research in the area is limited and further understanding of the etiology is likely to evolve as more patients and clinicians openly discuss this underreported condition. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/19/17720?source=see_link\">",
"     \"Chronic prostatitis/chronic pelvic pain syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CLASSIFICATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The male patient complaining of pelvic pain during sexual activity presents a challenge for the primary care clinician due to the absence of a uniformly accepted classification system.",
"   </p>",
"   <p>",
"    Male dyspareunia is felt to be a sexual pain disorder and has been defined by some as recurrent or persistent genital or pelvic pain associated with sexual activity or sexual dysfunction present for three months or longer [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19047/abstract/5\">",
"     5",
"    </a>",
"    ]. A psychological basis for some patients with dyspareunia has been addressed in the American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19047/abstract/6\">",
"     6",
"    </a>",
"    ]. In that classification, sexual pain disorder is considered as a subclassification of sexual dysfunction disorder.",
"   </p>",
"   <p>",
"    In general, male dyspareunia is divided into broad categories of underlying causes ranging from anatomic anomalies to psychosocial maladies. One classification system defines four broad categories (",
"    <a class=\"graphic graphic_table graphicRef75173 \" href=\"UTD.htm?31/20/32075\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19047/abstract/5\">",
"     5",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Isolated painful ejaculation",
"     </li>",
"     <li>",
"      Chronic",
"      <span class=\"nowrap\">",
"       prostatitis/chronic",
"      </span>",
"      pelvic pain",
"     </li>",
"     <li>",
"      Medical causes",
"     </li>",
"     <li>",
"      Other causes",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Isolated painful ejaculation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ejaculatory dysfunction is common and can be classified into anejaculation, delayed, retrograde, premature, and painful ejaculation [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19047/abstract/7\">",
"     7",
"    </a>",
"    ]. Among these disorders, painful ejaculation is the only ejaculatory condition where pain is the main complaint. The incidence of painful ejaculation among men age 50 years and older ranges from 1.0 to 6.7 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19047/abstract/8,9\">",
"     8,9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Common presentations of painful ejaculation can include penile pain, perineal ache, or suprapubic discomfort occurring during or after the ejaculatory period. Pain is sometimes experienced in the testicular or glans area of the penis immediately after ejaculation, or may result from perineal muscle spasm. Atypical pain with ejaculation can also occur in the abdomen, urethral meatus, or rectum.",
"   </p>",
"   <p>",
"    There are multiple causes of painful ejaculation (",
"    <a class=\"graphic graphic_table graphicRef56865 \" href=\"UTD.htm?9/21/9564\">",
"     table 2",
"    </a>",
"    ). Painful ejaculation can occur in many instances from ejaculatory duct obstruction [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19047/abstract/10\">",
"     10",
"    </a>",
"    ]. Intense perineal discomfort immediately after ejaculation can occur without evidence of infection or trauma [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19047/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Painful ejaculation can have a significant impact on a man's quality of life, negatively impacting self-esteem and reducing desire for sexual intercourse [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19047/abstract/12\">",
"     12",
"    </a>",
"    ]. Among men who report painful ejaculation, 90 percent considered this condition to be a serious problem [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19047/abstract/9,13\">",
"     9,13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Chronic prostatitis/chronic pelvic pain",
"    </span>",
"    &nbsp;&mdash;&nbsp;The chronic",
"    <span class=\"nowrap\">",
"     prostatitis/chronic",
"    </span>",
"    pelvic pain syndrome is frequently associated with male dyspareunia. Both inflammatory and non-inflammatory conditions of the prostate have been associated with chronic pelvic pain and painful intercourse. The chronic",
"    <span class=\"nowrap\">",
"     prostatitis/chronic",
"    </span>",
"    pelvic pain syndrome is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/19/17720?source=see_link\">",
"     \"Chronic prostatitis/chronic pelvic pain syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Medical causes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several medical causes of male dyspareunia have been described in case reports and small cohort studies.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Peyronie's disease is the formation of an inelastic scar or plaque of the tunica albuginea that may cause a pathological curvature of the penis and painful erections. Peyronie's is a common cause of chronic dyspareunia in men [",
"      <a class=\"abstract\" href=\"UTD.htm?18/38/19047/abstract/14\">",
"       14",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/55/17273?source=see_link\">",
"       \"Peyronie's disease: Diagnosis and medical management\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Phimosis leads to inability to retract the foreskin in the uncircumcised male and can cause discomfort with attempted intercourse [",
"      <a class=\"abstract\" href=\"UTD.htm?18/38/19047/abstract/15\">",
"       15",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/33/14872?source=see_link&amp;anchor=H20#H20\">",
"       \"Balanitis and balanoposthitis in adults\", section on 'Phimosis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Frenulum breve refers to a shortened frenulum which may restrict the glans in the erect state, causing pain with erections and attempts at intercourse.",
"     </li>",
"     <li>",
"      Hernia repair &mdash; Approximately 3 percent of males age 18 to 40 years of age reported moderate to severe pain-related sexual dysfunction following groin hernia repair in a nationwide Danish survey [",
"      <a class=\"abstract\" href=\"UTD.htm?18/38/19047/abstract/16\">",
"       16",
"      </a>",
"      ]. Only 1.8 percent of those men reporting dyspareunia consulted a clinician which may explain only sporadic reports of sexual dysfunction after inguinal herniorrhaphy. However, some men may desire further evaluation but do not seek it, as indicated by the finding that 8.5 percent of patients with dyspareunia in the survey wished to talk to a psychologist or clinician about their problems [",
"      <a class=\"abstract\" href=\"UTD.htm?18/38/19047/abstract/16\">",
"       16",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Pudendal nerve entrapment &mdash; Compression of the pudendal nerve within Alcock's canal or surrounding ligaments may cause pain and sexual dysfunction [",
"      <a class=\"abstract\" href=\"UTD.htm?18/38/19047/abstract/17\">",
"       17",
"      </a>",
"      ]. Oral",
"      <a class=\"drug drug_general\" href=\"UTD.htm?5/27/5561?source=see_link\">",
"       topiramate",
"      </a>",
"      and perineural injections of anaesthetics, such as bupivicaine, into the pudendal nerve with CT guidance have been successful in anecdotal cases [",
"      <a class=\"abstract\" href=\"UTD.htm?18/38/19047/abstract/18\">",
"       18",
"      </a>",
"      ]. Surgical decompression has also been effective [",
"      <a class=\"abstract\" href=\"UTD.htm?18/38/19047/abstract/19\">",
"       19",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Infections of the prostate, bladder, seminal vesicles, or urethra can lead to intense burning or itching sensations following ejaculation. Sexually transmitted diseases (eg, gonorrhea) may cause penile pain or burning associated with ejaculation as well as genital ulceration, such as in herpes simplex virus (HSV). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/43/19126?source=see_link\">",
"       \"Infectious causes of dysuria in adult men\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/30/490?source=see_link\">",
"       \"Screening for sexually transmitted infections\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Interstitial cystitis &mdash; Patients may experience intense pain at the moment of ejaculation and with intercourse. Compression of the bladder during intercourse causes pain sufficient enough to inhibit intercourse [",
"      <a class=\"abstract\" href=\"UTD.htm?18/38/19047/abstract/20\">",
"       20",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/8/8330?source=see_link\">",
"       \"Pathogenesis, clinical features, and diagnosis of interstitial cystitis/bladder pain syndrome\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Several dermatologic conditions of the penis have been associated with dyspareunia, including sexually transmitted diseases, lichen planus, lichen sclerosis, Zoon's (plasma cell) balanitis, balanoposthitis, and penile carcinoma [",
"      <a class=\"abstract\" href=\"UTD.htm?18/38/19047/abstract/14,21\">",
"       14,21",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/33/14872?source=see_link\">",
"       \"Balanitis and balanoposthitis in adults\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/13/26840?source=see_link\">",
"       \"Carcinoma of the penis: Epidemiology, risk factors, staging, and prognosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Some medications have been associated with male dyspareunia, including antidepressants and antipsychotics [",
"      <a class=\"abstract\" href=\"UTD.htm?18/38/19047/abstract/22-25\">",
"       22-25",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In the absence of any genitourinary abnormality, uncircumcised men are more likely than circumcised men to report dyspareunia [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19047/abstract/26\">",
"     26",
"    </a>",
"    ]. This association is not entirely explained by increased reports of scratches, abrasions, cuts, and bleeding with sexual intercourse in uncircumcised men.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H703048112\">",
"    <span class=\"h2\">",
"     Other causes",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Psychosocial",
"    </span>",
"    &nbsp;&mdash;&nbsp;Psychologic trauma has been found to cause male dyspareunia [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19047/abstract/27\">",
"     27",
"    </a>",
"    ]. Such psychologic trauma may include child abuse, relationship difficulties with partner, and body image issues.",
"   </p>",
"   <p>",
"    Guilt about sexual pleasure can lead to pain with sexual intercourse, including orgasm. This is most commonly expressed in patients from strict religious or cultural backgrounds who manifest intense negative feelings and pain at the time of orgasm.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Anodyspareunia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pain with receptive anal intercourse was found to occur in 14 percent of men who have sex with men in one study [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19047/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most conditions associated with male dyspareunia can be diagnosed with a thorough history and physical examination. Ancillary studies are usually unnecessary.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Clinical history",
"    </span>",
"    &nbsp;&mdash;&nbsp;The first step in the evaluation of male dyspareunia is a detailed clinical history.",
"   </p>",
"   <p>",
"    Possible correlative factors, such as non-specific neuropathy, anatomic abnormalities, trauma, urogenital infections, previous surgery, and medication history need to be reviewed. Symptoms suggestive of genital infection include dysuria, urethral discharge, and testicular",
"    <span class=\"nowrap\">",
"     swelling/tenderness.",
"    </span>",
"   </p>",
"   <p>",
"    Patients should also be asked if pain occurs with noncoital sexual activity, including masturbation. An underlying psychological basis should be considered for patients with dyspareunia who do not have pain with masturbation.",
"   </p>",
"   <p>",
"    If pain is not restricted to sexual activity, chronic",
"    <span class=\"nowrap\">",
"     prostatitis/chronic",
"    </span>",
"    pelvic pain syndrome should also be explored, which is a diagnosis of exclusion. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/19/17720?source=see_link\">",
"     \"Chronic prostatitis/chronic pelvic pain syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Particular attention should focus on urinary flow characteristics, ejaculation history, nocturnal erections, congenital or acquired disorders (eg, congenital chordee, Peyronie's disease), and the psychosexual sphere (eg, fears of affective relationships, pre-existent psychological abuse, previous psychological therapies).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;The physical examination focuses on genital and rectal areas with attention given to the status of the prostate, bulbocavernosus reflex, and anal sphincter tone.",
"   </p>",
"   <p>",
"    The penile examination pays particular attention to findings such as Peyronie's plaques, superficial lesions, short frenulum, and phimosis. The scrotum should be examined for testicular masses. Prostatic tenderness supports the diagnosis of acute prostatitis or chronic",
"    <span class=\"nowrap\">",
"     prostatitis/chronic",
"    </span>",
"    pelvic pain syndrome. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/42/4776?source=see_link\">",
"     \"Acute bacterial prostatitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/19/17720?source=see_link\">",
"     \"Chronic prostatitis/chronic pelvic pain syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Performing the bulbocavernosus reflex is important for initial diagnosis of pudendal nerve entrapment [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19047/abstract/17\">",
"     17",
"    </a>",
"    ]. The bulbocavernosus reflex is a polysynaptic reflex that is useful in testing S2-S4 nerve impairment. The test involves monitoring anal sphincter contraction in response to squeezing the glans penis. The absence of the reflex without reported sacral spinal cord trauma may indicate spinal shock or nerve entrapment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Ancillary studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Urinalysis",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    urine culture should be performed in patients with urinary complaints, which may identify infectious causes of male dyspareunia. If these studies are negative, patients with significant dyspareunia are generally referred to a urologic specialist for further evaluation.",
"   </p>",
"   <p>",
"    Microscopic evaluation of expressed prostatic secretions (EPS) after prostatic massage may be helpful when prostatic inflammation or infection is suspected.",
"   </p>",
"   <p>",
"    Radiological and urodynamic evaluations are rarely indicated, but may include cystoscopy, transrectal ultrasonography (TRUS), abdominal ultrasonography, computerized tomography, uroflowmetry, and specialized tests to rule out a neurogenic origin, abdominal masses, or congenital anomalies. Most of these studies are usually normal in patients with dyspareunia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Therapy for male dyspareunia is usually directed at the underlying cause, when this is identified. If no underlying cause is found, treatment modalities range from medication to psychosocial rehabilitation. When initial evaluation in primary care does not lead to a clear treatable cause of symptoms, most patients will require urologic referral for treatment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Pharmacotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Randomized trials of treatments for male dyspareunia are limited. Several randomized trials among patients with chronic",
"    <span class=\"nowrap\">",
"     prostatitis/chronic",
"    </span>",
"    pelvic pain syndrome have shown mixed results using various pharmacotherapies, and positive studies show only mild improvement in pain symptoms. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/19/17720?source=see_link\">",
"     \"Chronic prostatitis/chronic pelvic pain syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Alpha-blockers have been used in patients with idiopathic painful ejaculation. In observational studies, pain with ejaculation improved or resolved completely with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/28/39365?source=see_link\">",
"       tamsulosin",
"      </a>",
"      treatment (0.4 mg once daily) [",
"      <a class=\"abstract\" href=\"UTD.htm?18/38/19047/abstract/25,29\">",
"       25,29",
"      </a>",
"      ]. However, in a blinded trial of 118 men randomly assigned to tamsulosin or placebo, there was no significant difference in pain scores after six weeks of treatment [",
"      <a class=\"abstract\" href=\"UTD.htm?18/38/19047/abstract/30\">",
"       30",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      For patients with Peyronie's disease, pharmacotherapy has not been shown to be consistently effective. Oral",
"      <a class=\"drug drug_general\" href=\"UTD.htm?13/28/13765?source=see_link\">",
"       pentoxifylline",
"      </a>",
"      and intralesional verpamil have been reported to have modest benefit in reducing penile plaque size and curvature in patients with Peyronie's disease. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/55/17273?source=see_link\">",
"       \"Peyronie's disease: Diagnosis and medical management\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Medical treatments for postherniotomy dyspareunia include drugs targeting the contractility of the vas deferens such as alpha receptor blockers or agents effective in neuropathic pain [",
"      <a class=\"abstract\" href=\"UTD.htm?18/38/19047/abstract/31,32\">",
"       31,32",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Patients suffering from interstitial cystitis have been prescribed various therapies including pentosan,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?26/30/27112?source=see_link\">",
"       amitriptyline",
"      </a>",
"      , intravesical alkalinized",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/34/35360?source=see_link\">",
"       lidocaine",
"      </a>",
"      with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?39/34/40489?source=see_link\">",
"       heparin",
"      </a>",
"      , and intravesical botulinum toxin [",
"      <a class=\"abstract\" href=\"UTD.htm?18/38/19047/abstract/33\">",
"       33",
"      </a>",
"      ]. Pentosan and amitriptyline appear to be the most efficacious treatments. Combination therapy with two or more agents has also been advocated as optimal therapy for management of interstitial cystitis in men, depending on the symptoms of the individual patient [",
"      <a class=\"abstract\" href=\"UTD.htm?18/38/19047/abstract/34,35\">",
"       34,35",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Treatment for dyspareunia associated with dermatologic conditions, including sexually transmitted diseases, lichen planus, lichen sclerosis, Zoon's (plasma cell) balanitis, balanoposthitis, and penile carcinoma, is directed at the underlying condition. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/33/14872?source=see_link\">",
"       \"Balanitis and balanoposthitis in adults\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/21/42328?source=see_link\">",
"       \"Carcinoma of the penis: Clinical presentation and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      When no underlying etiology for male dyspareunia has been identified, we have occasionally prescribed courses of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?19/19/19768?source=see_link\">",
"       gabapentin",
"      </a>",
"      (starting dose 300 mg daily, gradual increase to 300 mg three times daily, maximum dose 1800 mg daily) or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?40/41/41624?source=see_link\">",
"       imipramine",
"      </a>",
"      (25 to 50 mg daily), based on their effectiveness in the management of chronic pain. Although there are no published data to support this approach, we have noted some improvement in symptoms in our clinical experience.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Surgical repair",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients afflicted with Peyronie's disease can be offered minimally invasive surgical options. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/1/42007?source=see_link\">",
"       \"Surgical management of Peyronie's disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For phimosis and frenulum breve, circumcision is the treatment of choice. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/33/14872?source=see_link&amp;anchor=H20#H20\">",
"       \"Balanitis and balanoposthitis in adults\", section on 'Phimosis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Surgical correction, including neurectomy, has been performed for post-herniotomy pelvic pain, with modest improvement in small case series [",
"      <a class=\"abstract\" href=\"UTD.htm?18/38/19047/abstract/36\">",
"       36",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/20/29000?source=see_link\">",
"       \"Overview of treatment for inguinal and femoral hernias\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Pudendal nerve entrapment can be treated with release of Alcock's canal, sacro-spinal, and sacro-tuberous ligaments. In a nonblinded trial of 32 patients randomly assigned to surgical decompression of the pudendal nerve compared to no surgery, there was significant improvement among patients receiving surgery (50 versus 1.6 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?18/38/19047/abstract/19\">",
"       19",
"      </a>",
"      ]. Both groups were offered steroid pudendal nerve blocks and physiotherapy.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Counseling/behavioral therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Individuals suffering from pain associated with sexual",
"    <span class=\"nowrap\">",
"     intercourse/ejaculation",
"    </span>",
"    are sometimes victims of sexual abuse or come from cultural backgrounds where sexual enjoyment is inappropriate. Once the clinician has identified a psychological basis for male dyspareunia, referral to the appropriate sexual counseling specialist is appropriate. Mental health counseling may improve pain symptoms in male patients with dyspareunia [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19047/abstract/5,27,37\">",
"     5,27,37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?42/60/43970?source=see_link\">",
"       \"Patient information: Dyspareunia (painful sex) (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Male dyspareunia is defined as recurrent or persistent genital or pelvic pain associated with sexual activity present for three months or longer. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Classification'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      While the exact prevalence is uncertain, approximately 1 percent of men complain of dyspareunia. However, prevalence may be underreported due to the social stigma associated with male dyspareunia. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Male dyspareunia can be divided into four broad categories: isolated painful ejaculation, chronic",
"      <span class=\"nowrap\">",
"       prostatitis/chronic",
"      </span>",
"      pelvic pain, medical causes, and other causes of sexual pain (",
"      <a class=\"graphic graphic_table graphicRef75173 \" href=\"UTD.htm?31/20/32075\">",
"       table 1",
"      </a>",
"      ). The underlying cause and pathophysiology of pain associated with sexual activity in males is not known in many cases. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Classification'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H3\">",
"       'Etiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The cause of male dyspareunia can often be diagnosed with a thorough history and physical examination. A urinalysis should be performed. Other laboratory studies are not indicated on a routine basis, but should be ordered by a urologist depending on the suspected etiology. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Therapy for male dyspareunia relies on correction of the underlying etiology. When initial evaluation in primary care does not lead to a clear treatable cause of symptoms, most patients will require urologic referral for treatment. For patients without a known cause of dyspareunia, we suggest medications effective in the treatment of chronic pain (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Possible choices include",
"      <a class=\"drug drug_general\" href=\"UTD.htm?19/19/19768?source=see_link\">",
"       gabapentin",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?40/41/41624?source=see_link\">",
"       imipramine",
"      </a>",
"      . (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Bancroft J. Human Sexuality and Its Problems, 3rd ed, Churchill Livingston, 2008.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19047/abstract/2\">",
"      Fugl-Meyer AR, Sjogren Fugl-Meyer K. Sexual disabilities, problems and satisfaction in 18-74 year old Swedes. Scand J Sexol 1999; 2:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19047/abstract/3\">",
"      Pitts M, Ferris J, Smith A, et al. Prevalence and correlates of three types of pelvic pain in a nationally representative sample of Australian men. J Sex Med 2008; 5:1223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19047/abstract/4\">",
"      Batstone GR, Doble A, Batstone D. Chronic prostatitis. Curr Opin Urol 2003; 13:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19047/abstract/5\">",
"      Luzzi G, Law L. A guide to sexual pain in men. Practitioner 2005; 249:73, 75, 77 passim.",
"     </a>",
"    </li>",
"    <li>",
"     American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed, American Psychiatric Association, Washington, DC 2000.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19047/abstract/7\">",
"      Colpi G, Weidner W, Jungwirth A, et al. EAU guidelines on ejaculatory dysfunction. Eur Urol 2004; 46:555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19047/abstract/8\">",
"      Blanker MH, Bosch JL, Groeneveld FP, et al. Erectile and ejaculatory dysfunction in a community-based sample of men 50 to 78 years old: prevalence, concern, and relation to sexual activity. Urology 2001; 57:763.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19047/abstract/9\">",
"      Rosen R, Altwein J, Boyle P, et al. Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol 2003; 44:637.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19047/abstract/10\">",
"      Smith JF, Walsh TJ, Turek PJ. Ejaculatory duct obstruction. Urol Clin North Am 2008; 35:221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19047/abstract/11\">",
"      Byrne LN, Meacham RB. Management of post-ejaculatory perineal pain. J Androl 2006; 27:710.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19047/abstract/12\">",
"      Ilie CP, Mischianu DL, Pemberton RJ. Painful ejaculation. BJU Int 2007; 99:1335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19047/abstract/13\">",
"      Vallancien G, Emberton M, Harving N, et al. Sexual dysfunction in 1,274 European men suffering from lower urinary tract symptoms. J Urol 2003; 169:2257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19047/abstract/14\">",
"      Basson R, Schultz WW. Sexual sequelae of general medical disorders. Lancet 2007; 369:409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19047/abstract/15\">",
"      Shechet J, Tanenbaum B, Fried SM. Male dyspareunia in the uncircumcised patient. Am Fam Physician 1999; 60:54, 56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19047/abstract/16\">",
"      Aasvang EK, M&oslash;hl B, Bay-Nielsen M, Kehlet H. Pain related sexual dysfunction after inguinal herniorrhaphy. Pain 2006; 122:258.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19047/abstract/17\">",
"      Popeney C, Ansell V, Renney K. Pudendal entrapment as an etiology of chronic perineal pain: Diagnosis and treatment. Neurourol Urodyn 2007; 26:820.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19047/abstract/18\">",
"      Filler AG. Diagnosis and treatment of pudendal nerve entrapment syndrome subtypes: imaging, injections, and minimal access surgery. Neurosurg Focus 2009; 26:E9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19047/abstract/19\">",
"      Robert R, Labat JJ, Bensignor M, et al. Decompression and transposition of the pudendal nerve in pudendal neuralgia: a randomized controlled trial and long-term evaluation. Eur Urol 2005; 47:403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19047/abstract/20\">",
"      Teichman JM, Parsons CL. Contemporary clinical presentation of interstitial cystitis. Urology 2007; 69:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19047/abstract/21\">",
"      Buechner SA. Common skin disorders of the penis. BJU Int 2002; 90:498.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19047/abstract/22\">",
"      Ellison JM. Antidepressant-induced sexual dysfunction: review, classification, and suggestions for treatment. Harv Rev Psychiatry 1998; 6:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19047/abstract/23\">",
"      Berger SH. Trifluoperazine and haloperidol: sources of ejaculatory pain? Am J Psychiatry 1979; 136:350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19047/abstract/24\">",
"      Aizenberg D, Zemishlany Z, Hermesh H, et al. Painful ejaculation associated with antidepressants in four patients. J Clin Psychiatry 1991; 52:461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19047/abstract/25\">",
"      Demyttenaere K, Huygens R. Painful ejaculation and urinary hesitancy in association with antidepressant therapy: relief with tamsulosin. Eur Neuropsychopharmacol 2002; 12:337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19047/abstract/26\">",
"      Mehta SD, Krieger JN, Agot K, et al. Circumcision and reduced risk of self-reported penile coital injuries: results from a randomized controlled trial in Kisumu, Kenya. J Urol 2010; 184:203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19047/abstract/27\">",
"      Gruver GG. Functional male dyspareunia: a case study. Am J Psychother 1977; 31:450.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19047/abstract/28\">",
"      Damon W, Rosser BR. Anodyspareunia in men who have sex with men: prevalence, predictors, consequences and the development of DSM diagnostic criteria. J Sex Marital Ther 2005; 31:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19047/abstract/29\">",
"      Barnas J, Parker M, Guhring P, Mulhall JP. The utility of tamsulosin in the management of orgasm-associated pain: a pilot analysis. Eur Urol 2005; 47:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19047/abstract/30\">",
"      Safarinejad MR. Safety and efficacy of tamsulosin in the treatment of painful ejaculation: a randomized, double-blind, placebo-controlled study. Int J Impot Res 2006; 18:527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19047/abstract/31\">",
"      Aasvang EK, M&oslash;hl B, Kehlet H. Ejaculatory pain: a specific postherniotomy pain syndrome? Anesthesiology 2007; 107:298.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19047/abstract/32\">",
"      Finnerup NB, Otto M, McQuay HJ, et al. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 2005; 118:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19047/abstract/33\">",
"      Seth A, Teichman JM. What's new in the diagnosis and management of painful bladder syndrome/interstitial cystitis? Curr Urol Rep 2008; 9:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19047/abstract/34\">",
"      Moldwin RM, Evans RJ, Stanford EJ, Rosenberg MT. Rational approaches to the treatment of patients with interstitial cystitis. Urology 2007; 69:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19047/abstract/35\">",
"      Parsons CL. Advances in the treatment of interstitial cystitis. Expert Opin Pharmacother 2006; 7:411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19047/abstract/36\">",
"      Aasvang E, Kehlet H. Surgical management of chronic pain after inguinal hernia repair. Br J Surg 2005; 92:795.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19047/abstract/37\">",
"      Kaplan HS. Post-ejaculatory pain syndrome. J Sex Marital Ther 1993; 19:91.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6886 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-110.137.129.113-854C4A8B72-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_38_19047=[""].join("\n");
var outline_f18_38_19047=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H18\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CLASSIFICATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Isolated painful ejaculation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Chronic prostatitis/chronic pelvic pain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Medical causes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H703048112\">",
"      Other causes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Psychosocial",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Anodyspareunia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Clinical history",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Ancillary studies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Pharmacotherapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Surgical repair",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Counseling/behavioral therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PC/6886\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/6886|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?31/20/32075\" title=\"table 1\">",
"      Proposed classifications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?9/21/9564\" title=\"table 2\">",
"      Etiologies painful ejaculation",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/42/4776?source=related_link\">",
"      Acute bacterial prostatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/1/43032?source=related_link\">",
"      Approach to the woman with sexual pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/33/14872?source=related_link\">",
"      Balanitis and balanoposthitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/21/42328?source=related_link\">",
"      Carcinoma of the penis: Clinical presentation and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/13/26840?source=related_link\">",
"      Carcinoma of the penis: Epidemiology, risk factors, staging, and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/19/17720?source=related_link\">",
"      Chronic prostatitis/chronic pelvic pain syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/43/19126?source=related_link\">",
"      Infectious causes of dysuria in adult men",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/44/42696?source=related_link\">",
"      Overview of male sexual dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/20/29000?source=related_link\">",
"      Overview of treatment for inguinal and femoral hernias",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/8/8330?source=related_link\">",
"      Pathogenesis, clinical features, and diagnosis of interstitial cystitis/bladder pain syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?42/60/43970?source=related_link\">",
"      Patient information: Dyspareunia (painful sex) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/55/17273?source=related_link\">",
"      Peyronie's disease: Diagnosis and medical management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/30/490?source=related_link\">",
"      Screening for sexually transmitted infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/1/42007?source=related_link\">",
"      Surgical management of Peyronie's disease",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f18_38_19048="Blepharitis";
var content_f18_38_19048=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Blepharitis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/38/19048/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/38/19048/contributors\">",
"     Roni M Shtein, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/38/19048/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/38/19048/contributors\">",
"     Jonathan Trobe, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/38/19048/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/38/19048/contributors\">",
"     Fenny H Lin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?18/38/19048/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 19, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Blepharitis is a chronic eye condition characterized by inflammation of the eyelids. Blepharitis is commonly evaluated by both primary care clinicians and ophthalmologists. One survey in the United States indicates that symptoms associated with blepharitis are quite common [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19048/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The most frequent patient complaint is of ongoing eye irritation, often accompanied by eye redness. The chronicity of blepharitis is punctuated by intermittent exacerbations.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLASSIFICATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Classification of blepharitis is sometimes based on the composition of tears and meibomian gland secretions. Although such classification is important for research into the etiology and treatment of blepharitis, this classification is not particularly helpful in providing clinical care. For the purpose of this review, we will discuss blepharitis according to its predominant anatomic location, as anterior or posterior.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Anterior blepharitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anterior blepharitis, less common than posterior, is characterized by inflammation at the base of the eyelashes (",
"    <a class=\"graphic graphic_picture graphicRef64540 \" href=\"UTD.htm?28/6/28771\">",
"     picture 1",
"    </a>",
"    ). Patients with anterior blepharitis, compared to those with posterior blepharitis, are more likely to be female and younger [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19048/abstract/2\">",
"     2",
"    </a>",
"    ]. Two variants of anterior blepharitis are identified: staphylococcal and seborrheic.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In staphylococcal anterior blepharitis, colonization of the eyelids by staphylococci leads to formation of fibrinous scales and crust around the eyelashes.",
"     </li>",
"     <li>",
"      The seborrheic variant is characterized by dandruff-like skin changes around the base of the eyelids, resulting in greasy scales around the eyelashes.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Posterior blepharitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Posterior blepharitis, the more common condition, is characterized by inflammation of the inner portion of the eyelid, at the level of the meibomian glands (",
"    <a class=\"graphic graphic_picture graphicRef61924 \" href=\"UTD.htm?25/60/26562\">",
"     picture 2",
"    </a>",
"    ). It is often described as meibomian gland dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19048/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Meibomian glands are modified sebaceous glands located within the tarsal plates of the eyelids. These glands are responsible for secretion of the oily layer of the tear film. This oily layer prevents tear evaporation, reduces the surface tension of the tear layer, and facilitates the spread of tears over the eye [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19048/abstract/4\">",
"     4",
"    </a>",
"    ]. It is critical for normal lubrication of the eye.",
"   </p>",
"   <p>",
"    Posterior blepharitis can be associated with rosacea or seborrheic dermatitis. Symptoms of these conditions are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/40/3721?source=see_link&amp;anchor=H2#H2\">",
"     \"Overview of dermatitis\", section on 'Seborrheic dermatitis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/28/21961?source=see_link\">",
"     \"Seborrheic dermatitis in adolescents and adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/46/36584?source=see_link\">",
"     \"Rosacea: Pathogenesis, clinical features, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Anterior blepharitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathophysiology of blepharitis is not completely understood. A role for lid-colonizing staphylococcal bacteria was first noted in 1946 [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19048/abstract/5\">",
"     5",
"    </a>",
"    ]. Several mechanisms by which staphylococci may alter meibomian gland secretion and cause blepharitis are supported by studies [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19048/abstract/6-9\">",
"     6-9",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Direct infection of the lids",
"     </li>",
"     <li>",
"      Evoke reaction to staphylococcal exotoxin",
"     </li>",
"     <li>",
"      Provoke allergic response to staphylococcal antigens [",
"      <a class=\"abstract\" href=\"UTD.htm?18/38/19048/abstract/10\">",
"       10",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    It is likely that a combination of these is responsible for the clinical manifestations of staphylococcal blepharitis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Posterior blepharitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Posterior blepharitis is characterized by inflammation around the meibomian glands. A single row of meibomian glands is present in each lid with openings just anterior to the mucocutaneous junction of the lid margin [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19048/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    As noted above, posterior blepharitis is often found in association with skin conditions such as rosacea and seborrheic dermatitis [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19048/abstract/2\">",
"     2",
"    </a>",
"    ]. Rosacea is associated with plugging and hypertrophy of the sebaceous glands [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19048/abstract/11\">",
"     11",
"    </a>",
"    ]. Since the meibomian glands are modified sebaceous glands, rosacea may lead directly to meibomian dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19048/abstract/4\">",
"     4",
"    </a>",
"    ]. Seborrheic dermatitis is also associated with inflammation of the meibomian glands and tear film instability [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19048/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An early finding in patients with blepharitis is hyperkeratinization of the meibomian gland ductal epithelium [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19048/abstract/13\">",
"     13",
"    </a>",
"    ]. Additionally, there is a change in the composition of meibomian gland secretions. Secretions from affected patients contain an increase in the concentration of free fatty acids and in the percentage of lipids with higher melting points [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19048/abstract/2,14-16\">",
"     2,14-16",
"    </a>",
"    ]. Levels of unsaturated fatty acids and other polar lipids are also increased in the meibomian secretions of patients with blepharitis [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19048/abstract/17,18\">",
"     17,18",
"    </a>",
"    ]. The differences in lipid composition are thought to be due to both altered production by the abnormal meibomian glands and to chemical changes in the secretions mediated by lipase that is produced by the colonizing bacterial flora on the ocular surface [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19048/abstract/4,6,19\">",
"     4,6,19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The bacteria that comprise the lid and conjunctival flora in blepharitis are the same as normal skin flora, but are present in greater numbers [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19048/abstract/8\">",
"     8",
"    </a>",
"    ]. The lid flora is composed principally of coagulase negative staphylococci, corynebacterium species, and propionibacterium acnes [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19048/abstract/2,7,14\">",
"     2,7,14",
"    </a>",
"    ]. Bacterial lipase is increased in patients with chronic blepharitis [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19048/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The altered meibomian gland secretions result in an impaired lipid layer of the tear film and instability of the tear film [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19048/abstract/20\">",
"     20",
"    </a>",
"    ]. The abnormal secretions also have a direct toxic effect on the ocular surface [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19048/abstract/10,16\">",
"     10,16",
"    </a>",
"    ]. Additionally, the altered lipid composition provides an environment that promotes bacterial growth, leading to a cycle of ongoing exacerbation of the meibomian gland abnormalities. Long term gland inflammation leads to fibrosis, dysfunction of the glands, and damage to the eyelid and ocular surface.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     CLINICAL PRESENTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with blepharitis often present with symptoms of chronic eye irritation. Common complaints include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Red eyes",
"     </li>",
"     <li>",
"      Gritty sensation",
"     </li>",
"     <li>",
"      Burning sensation",
"     </li>",
"     <li>",
"      Excessive tearing",
"     </li>",
"     <li>",
"      Itchy eyelids",
"     </li>",
"     <li>",
"      Red, swollen eyelids",
"     </li>",
"     <li>",
"      Crusting or matting of eyelashes in the morning",
"     </li>",
"     <li>",
"      Flaking or scaling of the eyelid skin",
"     </li>",
"     <li>",
"      Light sensitivity",
"     </li>",
"     <li>",
"      Blurred vision",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     CLINICAL EXAMINATION AND DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of blepharitis is clinical, based on the patient's history and physical examination findings. There are no confirmatory diagnostic tests or laboratory investigations.",
"   </p>",
"   <p>",
"    The history should include questions about symptom duration, smoking, allergens, contact lenses, and use of retinoids, which may provoke or exacerbate symptoms. A history of acne, rosacea, or eczema should be evaluated [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19048/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     External examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;The patient's facial and scalp skin should be examined for findings typical of seborrheic dermatitis (itching and flaking scalp or facial skin) or acne rosacea (facial flushing, broken or swollen blood vessels on cheeks and nose, and a red or swollen nose).",
"   </p>",
"   <p>",
"    The eyelid edges will often appear pink or irritated. Crusting of the lashes or lid margins may also be visible. The lids should be examined carefully, using a focused light source (penlight or otoscope lamp) if a slit lamp is not available. Patients with anterior blepharitis will typically have adherent material around their eyelashes. In the seborrheic variant these are often greasy appearing flakes; whereas in staphylococcal blepharitis, a hard crust develops around the eyelash as a \"collarette\" [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19048/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Malposition of the eyelids should be evaluated. Chronic inflammation can lead to structural changes resulting in entropion (inward turning of eyelid) (",
"    <a class=\"graphic graphic_picture graphicRef63579 \" href=\"UTD.htm?41/61/42964\">",
"     picture 3",
"    </a>",
"    ) or ectropion (outward turning of eyelid) (",
"    <a class=\"graphic graphic_picture graphicRef72737 \" href=\"UTD.htm?19/16/19714\">",
"     picture 4",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Eyelashes should be carefully evaluated as chronic inflammation can lead to trichiasis (misdirected eyelashes), madarosis (loss of lashes), poliosis (loss of pigmentation of lashes), or distichiasis (abnormal growth of eyelashes from meibomian gland orifices).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Slit lamp examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Slit lamp examination is routinely performed when patients are referred to ophthalmology for evaluation, but is not necessary for initial treatment of blepharitis by primary care clinicians.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Eyelids",
"    </span>",
"    &nbsp;&mdash;&nbsp;The slit lamp examination can help distinguish anterior and posterior blepharitis. Changes in anterior blepharitis, suggestive of seborrheic or staphylococcal variants, are described above. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'External examination'",
"    </a>",
"    above.) In posterior blepharitis it is common to see enlargement of the meibomian gland openings and plugging with thickened, waxy secretions appearing as white or yellow mounds at the gland opening (",
"    <a class=\"graphic graphic_picture graphicRef53663 \" href=\"UTD.htm?24/10/24736\">",
"     picture 5",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    With any form of blepharitis, chronic inflammation can lead to neovascularization and dilation of existing blood vessels of the lid margin, thickening of the lid skin, irregularity of the lid contour, and ulcerations along the eyelid margin.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Conjunctiva",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with blepharitis will often develop diffuse conjunctival injection. This injection is sometimes more prominent on the palpebral conjunctiva [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19048/abstract/4\">",
"     4",
"    </a>",
"    ]. Blepharitis can also be associated with a papillary conjunctival reaction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Tear film",
"    </span>",
"    &nbsp;&mdash;&nbsp;Irregularities of tear film are identifiable by the presence of debris",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    a foamy appearance to the tear film. Abnormalities of tear film stability are assessed by increased tear break up time and increased tear evaporation rate.",
"   </p>",
"   <p>",
"    Tear break up time is evaluated by examining the tear film with a slit lamp using blue light, after instilling",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/27/29108?source=see_link\">",
"     fluorescein",
"    </a>",
"    stain in the eye. A healthy tear film appears as a green sheen that remains stable for at least ten seconds. An abnormal tear film becomes irregular or breaks up in less than ten seconds.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Cornea",
"    </span>",
"    &nbsp;&mdash;&nbsp;Corneal findings are most commonly found where the inflamed lid margins cross the cornea at the two, four, eight, and ten o'clock positions.",
"   </p>",
"   <p>",
"    Punctate epithelial erosions commonly appear in the inferior third of the cornea [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19048/abstract/10\">",
"     10",
"    </a>",
"    ]. Similar erosions may be associated with dry eyes, but in that condition are more commonly distributed throughout the inter-palpebral space.",
"   </p>",
"   <p>",
"    Patients with blepharitis can develop marginal corneal infiltrates as a hypersensitivity reaction to staphylococcal antigens [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19048/abstract/23\">",
"     23",
"    </a>",
"    ]. These appear as a superficial stromal infiltrate, usually with epithelial breakdown, near the limbus. An area of clear cornea between the limbus and the infiltrate is characteristic.",
"   </p>",
"   <p>",
"    Corneal nodules, called phlyctenules, develop near the limbus and then spread onto the cornea, carrying behind them a leash of vessels. They are considered to be another form of hypersensitivity reaction to staphylococcal antigens [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19048/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Rarely, corneal marginal ulcers can develop in the setting of blepharitis. These must be recognized and treated appropriately to avoid progression to corneal perforation.",
"   </p>",
"   <p>",
"    Chronic irritation and recurrent corneal infiltrates can lead to scarring and development of a superficial corneal pannus, sometimes described as pseudo-pterygium (",
"    <a class=\"graphic graphic_picture graphicRef81259 \" href=\"UTD.htm?9/30/9711\">",
"     picture 6",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     ASSOCIATED OCULAR CONDITIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Hordeolum",
"    </span>",
"    &nbsp;&mdash;&nbsp;A hordeolum (commonly referred to as a stye) is an acute infection of an oil gland of the eyelid that presents as an abrupt onset of a red tender bump on the eyelid (",
"    <a class=\"graphic graphic_picture graphicRef79059 \" href=\"UTD.htm?2/54/2916\">",
"     picture 7",
"    </a>",
"    ). It can be associated with blepharitis because abnormal oily secretions block lid glands that may become secondarily infected. Treatment involves application of warm moist compresses four times a day. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/63/4088?source=see_link&amp;anchor=H7#H7\">",
"     \"Eyelid lesions\", section on 'Hordeolum'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Chalazion",
"    </span>",
"    &nbsp;&mdash;&nbsp;A chalazion is a firm non-tender bump on the eyelid that represents a chronic sterile inflammation of an oil gland of the eyelid (",
"    <a class=\"graphic graphic_picture graphicRef62030 \" href=\"UTD.htm?23/30/24034\">",
"     picture 8",
"    </a>",
"    ). The chalazion results from a granulomatous inflammatory reaction to the lipid content of the blocked lid gland [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19048/abstract/4\">",
"     4",
"    </a>",
"    ]. Treatment involves application of warm, moist compresses four times a day. If the symptoms do not respond after several weeks, incision and curettage or intralesional glucocorticoid injection can be performed. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/63/4088?source=see_link&amp;anchor=H5#H5\">",
"     \"Eyelid lesions\", section on 'Chalazion'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Dry eye",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with blepharitis should be asked about symptoms of dry eyes (",
"    <a class=\"graphic graphic_picture graphicRef62824 \" href=\"UTD.htm?17/19/17714\">",
"     picture 9",
"    </a>",
"    ). Abnormal or decreased meibomian gland secretions lead to alterations in the tear film that can result in excess tearing or dry eye. A 25 to 40 percent incidence of dry eyes has been found in patients with blepharitis [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19048/abstract/25\">",
"     25",
"    </a>",
"    ]. Patients often need to use supplemental artificial tear eye drops to treat the dryness. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/11/25784?source=see_link\">",
"     \"Dry eyes\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Contact lens intolerance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Blepharitis is a common finding in patients with contact lens intolerance [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19048/abstract/26\">",
"     26",
"    </a>",
"    ]. The altered lipid layer of the tear film in patients with blepharitis results in reduced contact lens comfort for some patients. Treatment of blepharitis as well as supplemental ocular lubrication may improve contact lens tolerance.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most important initial component of blepharitis treatment is patient education and counseling. Blepharitis is a chronic condition without definitive cure, and a satisfactory result therefore requires a long-term commitment to treatment and appropriate expectations. Goals of treatment are to alleviate acute symptoms of an exacerbation and to develop a maintenance regimen to prevent or minimize future exacerbations.",
"   </p>",
"   <p>",
"    Good lid hygiene is the mainstay of treatment for all forms of blepharitis and should be emphasized in both the acute and maintenance phases of treatment. Recommendations about self-care hygiene and other interventions are based on clinical experience, as randomized trials have not been reported on specific components of self-care.",
"   </p>",
"   <p>",
"    A systematic review of 34 studies (randomized trials and case control studies) of treatments for chronic anterior or posterior blepharitis found that lid hygiene measures provided effective symptom relief for both anterior and posterior blepharitis [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19048/abstract/27\">",
"     27",
"    </a>",
"    ]. The review found that topical antibiotics were effective for providing symptom relief and eradicating bacteria at the lid margin for patients with anterior blepharitis, but did not find conclusive evidence of effectiveness for oral antibiotics or topical glucocorticoids.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Warm compresses",
"    </span>",
"    &nbsp;&mdash;&nbsp;Application of heat to the lids and meibomian glands can liquefy the abnormal solidified meibomian secretions by heating them above their melting point. Heat may also promote increased circulation in the meibomian glands and thereby increase the quantity of secretions.",
"   </p>",
"   <p>",
"    Patients are advised to soak a wash cloth in warm (not scalding) water and place it over the eyes. As the wash cloth cools, it should be re-warmed and replaced for a total of five to ten minutes of soaking time. This is recommended two to four times a day during the acute phase and at a decreased frequency in the maintenance phase of treatment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Lid massage",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lid massage may help empty the meibomian glands and improve secretion, especially in patients with posterior blepharitis and meibomian gland inspissation. Lid massage should be performed immediately following application of a warm compress. Either the wash cloth that was used for the compress or a clean fingertip should be used to gently massage the edge of the eyelid towards the eye with a gentle circular motion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Lid washing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with significant accumulation of debris on the eyelashes may benefit from gentle washing of the eyelid margins following use of the warm compress. Either warm water or very dilute baby shampoo can be placed on a clean wash cloth, gauze pad, or cotton swab. The patient is then advised to gently clean along the lashes and lid margin to remove the accumulated material on the lashes with care to avoid contacting the ocular surface. Vigorous washing should be avoided, as this may incite more irritation of the sensitive eyelid skin.",
"   </p>",
"   <p>",
"    Commercially available eyelid scrub solutions are safe and effective [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19048/abstract/28\">",
"     28",
"    </a>",
"    ] and may be preferred for their convenience and ease of use [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19048/abstract/29\">",
"     29",
"    </a>",
"    ]. If any soap is used, thorough rinsing is recommended.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Antibiotics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Since bacterial overgrowth and the lipase activity of colonizing bacteria are known to play a role in the pathophysiology of blepharitis, there is a role for antibiotics in treatment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h3\">",
"     Topical antibiotics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Topical antibiotic ointments may be helpful in reducing the bacterial load of the lashes and conjunctiva. The ointment is placed directly onto the lid margin up to four times a day. Many prefer to use the antibiotic once daily at bedtime only, since the ointment can cause significant blurring of vision.",
"   </p>",
"   <p>",
"    Topical",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/43/33456?source=see_link\">",
"     azithromycin",
"    </a>",
"    ophthalmic solution 1 percent has been shown to improve meibomian gland secretions and to decrease eyelid redness, compared to use of warm compresses alone [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19048/abstract/30\">",
"     30",
"    </a>",
"    ]. A four-week course of topical azithromycin leads to significant improvement in both signs and symptoms of blepharitis [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19048/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/29/36304?source=see_link\">",
"     Erythromycin",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/20/6469?source=see_link\">",
"     bacitracin",
"    </a>",
"    ointments are often prescribed as they have broad spectrum antimicrobial activity and tend to be well-tolerated [26]. Although they can sometimes be associated with contact dermatitis, these ointments are usually the first line of topical antibiotic treatment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h3\">",
"     Oral antibiotics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Long term use of oral antibiotics, especially tetracyclines, may be helpful in severe cases of blepharitis. Tetracyclines effectively reduce the load of colonizing lid and conjunctival bacteria [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19048/abstract/32\">",
"     32",
"    </a>",
"    ]. Tetracyclines also decrease keratinization [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19048/abstract/33\">",
"     33",
"    </a>",
"    ] and bacterial lipase production [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19048/abstract/34,35\">",
"     34,35",
"    </a>",
"    ]. Tetracyclines may be especially useful in patients with ocular manifestations of rosacea [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19048/abstract/36\">",
"     36",
"    </a>",
"    ]. Furthermore, they are associated with reduction of matrix metalloproteinase activity that may play a role in chronic blepharitis [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19048/abstract/37\">",
"     37",
"    </a>",
"    ]. However, trials comparing",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/49/2840?source=see_link\">",
"     tetracycline",
"    </a>",
"    with placebo in patients with blepharitis are not available.",
"   </p>",
"   <p>",
"    Treatment can be initiated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/41/2714?source=see_link\">",
"     doxycycline",
"    </a>",
"    100 mg or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/49/2840?source=see_link\">",
"     tetracycline",
"    </a>",
"    1000 mg daily in divided doses and tapered after improvement (often two to four weeks) to doxycycline 50 mg or tetracycline 250 to 500 mg daily. Treatment can be given in intermittent courses, as indicated by symptom exacerbation. Tetracyclines may cause photosensitization, gastrointestinal upset, and pseudotumor cerebri, as well as interfere with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    and the effectiveness of oral contraceptives.",
"   </p>",
"   <p>",
"    Tetracyclines are contraindicated in pregnant or nursing women, and in children under 12 years of age. In lieu of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/49/2840?source=see_link\">",
"     tetracycline",
"    </a>",
"    and its derivatives,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/29/36304?source=see_link\">",
"     erythromycin",
"    </a>",
"    or related medications should be used in pregnant patients or children under the age of 12.",
"   </p>",
"   <p>",
"    One small study of adult patients with posterior blepharitis found symptomatic improvement after treatment with intermittent oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/43/33456?source=see_link\">",
"     azithromycin",
"    </a>",
"    therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19048/abstract/38\">",
"     38",
"    </a>",
"    ]. Further studies are needed to determine whether intermittent antibiotic therapy is an effective option for treatment of blepharitis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Topical glucocorticoids",
"    </span>",
"    &nbsp;&mdash;&nbsp;There may be a role for topical glucocorticoid use in the short term treatment of acute blepharitis exacerbations [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19048/abstract/39\">",
"     39",
"    </a>",
"    ]. Patients should generally be evaluated by an ophthalmologist prior to initiation of topical glucocorticoids.",
"   </p>",
"   <p>",
"    It should be emphasized that topical glucocorticoids are not to be used chronically to avoid increasing risk for glaucoma or cataract formation. Furthermore, steroid use can rarely lead to corneal thinning and perforation [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19048/abstract/40\">",
"     40",
"    </a>",
"    ], particularly in patients with a potentially compromised ocular surface. If glucocorticoids are prescribed, patients should be reevaluated in a few weeks to measure intraocular pressure and to determine response.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Topical cyclosporine",
"    </span>",
"    &nbsp;&mdash;&nbsp;Topical",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    0.05 percent eye drops were approved for the treatment of dry eyes by the US FDA in 2002. Several studies have investigated off-label use of these drops in the treatment of blepharitis with promising results. Topical cyclosporine use has led to reduction in symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19048/abstract/41\">",
"     41",
"    </a>",
"    ] and improved clinical findings in patients with posterior blepharitis [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19048/abstract/41,42\">",
"     41,42",
"    </a>",
"    ]. Due to its high cost, cyclosporine should be a therapeutic option only when traditional treatments are ineffective.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27856499\">",
"    <span class=\"h2\">",
"     Thermal pulsation systems",
"    </span>",
"    &nbsp;&mdash;&nbsp;Devices are available to provide heat and gentle pressure on the eyelid to liquefy and release obstructions in the meibomian glands. In one industry-sponsored, open-label, randomized trial, the LipiFlow&reg; system applied for one 12-minute treatment improved meibomian gland secretion and dry eye symptoms at two and four weeks compared to warm compresses used for five minutes once daily [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19048/abstract/43\">",
"     43",
"    </a>",
"    ]. Whether these short-term results would persist beyond four weeks is not known.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Future treatments",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several topical medications are under evaluation as treatment for blepharitis. Topical",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/38/20065?source=see_link\">",
"     metronidazole",
"    </a>",
"    is a potential substitute for the use of systemic antibiotics, especially in cases of blepharitis related to rosacea [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19048/abstract/44\">",
"     44",
"    </a>",
"    ]. Topical",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/14/32992?source=see_link\">",
"     tacrolimus",
"    </a>",
"    ointment has been used to treat severe refractory blepharitis with good results [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19048/abstract/45\">",
"     45",
"    </a>",
"    ]. Development of effective tear lipid substitutes may palliate the symptoms of blepharitis [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19048/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h1\">",
"     SPECIAL CASES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h2\">",
"     Unilateral symptoms and possible malignancy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Blepharitis is nearly always bilateral. A malignant tumor of the lid skin (ie, sebaceous carcinoma) should be suspected in a patient with persistent unilateral eyelid inflammation (",
"    <a class=\"graphic graphic_picture graphicRef70403 \" href=\"UTD.htm?10/8/10370\">",
"     picture 10",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19048/abstract/47-50\">",
"     47-50",
"    </a>",
"    ]. Other symptoms of malignancy include failure to respond to treatment, a nodular mass, ulceration, extensive scarring, or conjunctival nodules surrounded by inflammation [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19048/abstract/21\">",
"     21",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/63/4088?source=see_link&amp;anchor=H16#H16\">",
"     \"Eyelid lesions\", section on 'Sebaceous carcinoma'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Early recognition of malignancy can reduce morbidity and mortality. Unusual forms of blepharitis should alert the physician to consider biopsy for a pathologic diagnosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h2\">",
"     Preoperative patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;Care must be taken to diagnose and treat blepharitis in patients prior to proceeding with eye surgery, since blepharitis is associated with increased bacterial colonization of the eyelids [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19048/abstract/51\">",
"     51",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h2\">",
"     Pediatric blepharitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children can have dramatic episodes of anterior",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    posterior blepharitis, often characterized by more conjunctival and corneal findings than in adults [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19048/abstract/52,53\">",
"     52,53",
"    </a>",
"    ]. Accurate diagnosis and appropriate treatment in these children is important in order to minimize long-term sequelae of blepharitis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H35\">",
"    <span class=\"h2\">",
"     Allergic blepharitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Allergic blepharitis is an acute inflammatory reaction of the skin of the eyelids, usually occurring as a reaction to a contact irritant [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19048/abstract/54\">",
"     54",
"    </a>",
"    ]. The skin of the eyelids will be typically very red, swollen, and itchy. Treatment is aimed at identifying and eliminating use of the offending agent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H36\">",
"    <span class=\"h2\">",
"     Demodex folliculorum",
"    </span>",
"    &nbsp;&mdash;&nbsp;Demodex is a parasite that commonly inhabits the eyelash follicle in patients with and without blepharitis [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19048/abstract/55,56\">",
"     55,56",
"    </a>",
"    ]. Although this parasite can cause some changes in the eyelash follicles, there is no evidence that it is directly associated with blepharitis [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19048/abstract/56\">",
"     56",
"    </a>",
"    ]. Ocular demodex folliculorum can be treated with oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/13/32976?source=see_link\">",
"     ivermectin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19048/abstract/57\">",
"     57",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?30/29/31185?source=see_link\">",
"       \"Patient information: Blepharitis (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?33/39/34417?source=see_link\">",
"       \"Patient information: Stye (hordeolum) (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?17/56/18305?source=see_link\">",
"       \"Patient information: Chalazion (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H37\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Blepharitis is a chronic eye condition characterized by inflammation of the eyelids, with intermittent acute exacerbations. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Anterior blepharitis primarily affects the eyelashes and is related to staphylococcal colonization or seborrhea. Posterior blepharitis is more common and results from meibomian gland dysfunction, which affects tear composition. Posterior blepharitis may be associated with rosacea or seborrheic dermatitis. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Classification'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Diagnosis of blepharitis is based on clinical findings. A slit lamp examination may be helpful in evaluating characteristic features of the lids, conjunctiva, tear film, and cornea. Patients should be evaluated for concurrent dry eyes. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Clinical examination and diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Treatment involves patient education about disease chronicity and need for long-term commitment to a therapy program involving lid hygiene. We recommend regular application of warm compresses, gentle lid massage, and lid washing (",
"      <a class=\"grade\" href=\"._grade_3?title=Grade 1C\">",
"       Grade 1C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest topical or systemic antibiotics for more severe cases that do not respond to initial lid hygiene (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Topical (",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/29/36304?source=see_link\">",
"       erythromycin",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?6/20/6469?source=see_link\">",
"       bacitracin",
"      </a>",
"      ointment) or oral (",
"      <a class=\"drug drug_general\" href=\"UTD.htm?2/49/2840?source=see_link\">",
"       tetracycline",
"      </a>",
"      ) antibiotics are appropriate. Topical glucocorticoids should be reserved for short-term treatment of acute exacerbations. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with unilateral or other unusual symptoms should be evaluated for the possibility of a sebaceous cell malignancy. Blepharitis should be treated prior to ophthalmologic surgery to decrease risk of bacterial contamination. (See",
"      <a class=\"local\" href=\"#H31\">",
"       'Special cases'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19048/abstract/1\">",
"      Lemp MA, Nichols KK. Blepharitis in the United States 2009: a survey-based perspective on prevalence and treatment. Ocul Surf 2009; 7:S1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19048/abstract/2\">",
"      McCulley JP, Dougherty JM, Deneau DG. Classification of chronic blepharitis. Ophthalmology 1982; 89:1173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19048/abstract/3\">",
"      Nichols KK, Foulks GN, Bron AJ, et al. The international workshop on meibomian gland dysfunction: executive summary. Invest Ophthalmol Vis Sci 2011; 52:1922.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19048/abstract/4\">",
"      Driver PJ, Lemp MA. Meibomian gland dysfunction. Surv Ophthalmol 1996; 40:343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19048/abstract/5\">",
"      Thygeson, P. The etiology and treatment of blepharitis: a study in military personnel. Arch Ophthalmol 1946; 98:191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19048/abstract/6\">",
"      Dougherty JM, McCulley JP. Comparative bacteriology of chronic blepharitis. Br J Ophthalmol 1984; 68:524.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19048/abstract/7\">",
"      Groden LR, Murphy B, Rodnite J, Genvert GI. Lid flora in blepharitis. Cornea 1991; 10:50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19048/abstract/8\">",
"      McCulley JP, Dougherty JM. Bacterial aspects of chronic blepharitis. Trans Ophthalmol Soc U K 1986; 105 ( Pt 3):314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19048/abstract/9\">",
"      Dougherty JM, McCulley JP. Bacterial lipases and chronic blepharitis. Invest Ophthalmol Vis Sci 1986; 27:486.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19048/abstract/10\">",
"      Smith RE, Flowers CW Jr. Chronic blepharitis: a review. CLAO J 1995; 21:200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19048/abstract/11\">",
"      Burton JL, Pye RJ, Meyrick G, Shuster S. The sebum excretion rate in rosacea. Br J Dermatol 1975; 92:541.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19048/abstract/12\">",
"      Karalezli A, Borazan M, Dursun R, et al. Impression cytology and ocular surface characteristics in patients with seborrhoeic dermatitis. Acta Ophthalmol 2011; 89:e137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19048/abstract/13\">",
"      Gutgesell VJ, Stern GA, Hood CI. Histopathology of meibomian gland dysfunction. Am J Ophthalmol 1982; 94:383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19048/abstract/14\">",
"      McCulley JP, Dougherty JM. Blepharitis associated with acne rosacea and seborrheic dermatitis. Int Ophthalmol Clin 1985; 25:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19048/abstract/15\">",
"      Shine WE, McCulley JP. Meibomian gland triglyceride fatty acid differences in chronic blepharitis patients. Cornea 1996; 15:340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19048/abstract/16\">",
"      Dougherty JM, McCulley JP. Analysis of the free fatty acid component of meibomian secretions in chronic blepharitis. Invest Ophthalmol Vis Sci 1986; 27:52.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19048/abstract/17\">",
"      Shine WE, McCulley JP. Polar lipids in human meibomian gland secretions. Curr Eye Res 2003; 26:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19048/abstract/18\">",
"      Shine WE, McCulley JP. Meibomianitis: polar lipid abnormalities. Cornea 2004; 23:781.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19048/abstract/19\">",
"      McCulley JP, Shine WE. The lipid layer of tears: dependent on meibomian gland function. Exp Eye Res 2004; 78:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19048/abstract/20\">",
"      Baudouin C. The pathology of dry eye. Surv Ophthalmol 2001; 45 Suppl 2:S211.",
"     </a>",
"    </li>",
"    <li>",
"     American Academy of Ophthalmology. Blepharitis: Preferred Practice Pattern. Available at: file://one.aao.org/CE/PracticeGuidelines/Snippet.aspx?cid=7802696a-baaa-4b10-afda-f95992f81784 (Accessed on October 10, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19048/abstract/22\">",
"      Gilbard JP. Dry eye, blepharitis and chronic eye irritation: divide and conquer. J Ophthalmic Nurs Technol 1999; 18:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19048/abstract/23\">",
"      Smolin G, Okumoto M. Staphylococcal blepharitis. Arch Ophthalmol 1977; 95:812.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19048/abstract/24\">",
"      Mondino BJ. Inflammatory diseases of the peripheral cornea. Ophthalmology 1988; 95:463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19048/abstract/25\">",
"      Bowman RW, Dougherty JM, McCulley JP. Chronic blepharitis and dry eyes. Int Ophthalmol Clin 1987; 27:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19048/abstract/26\">",
"      Henriquez AS, Korb DR. Meibomian glands and contact lens wear. Br J Ophthalmol 1981; 65:108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19048/abstract/27\">",
"      Lindsley K, Matsumura S, Hatef E, Akpek EK. Interventions for chronic blepharitis. Cochrane Database Syst Rev 2012; 5:CD005556.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19048/abstract/28\">",
"      Polack FM, Goodman DF. Experience with a new detergent lid scrub in the management of chronic blepharitis. Arch Ophthalmol 1988; 106:719.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19048/abstract/29\">",
"      Key JE. A comparative study of eyelid cleaning regimens in chronic blepharitis. CLAO J 1996; 22:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19048/abstract/30\">",
"      Luchs J. Efficacy of topical azithromycin ophthalmic solution 1% in the treatment of posterior blepharitis. Adv Ther 2008; 25:858.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19048/abstract/31\">",
"      Sahli E, Hoal BM, Zileliolu G, et al. The effect of topical cyclosporine A on clinical findings and cytological grade of the disease in patients with dry eye. Cornea 2010; 29:1412.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19048/abstract/32\">",
"      Ta CN, Shine WE, McCulley JP, et al. Effects of minocycline on the ocular flora of patients with acne rosacea or seborrheic blepharitis. Cornea 2003; 22:545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19048/abstract/33\">",
"      Cullen SI, Crounse RG. Cutaneous pharmacology of the tetracyclines. J Invest Dermatol 1965; 45:263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19048/abstract/34\">",
"      Mates A. Inhibition by tetracycline in the occurrence of extracellular lipase from Staphylococcus aureus. Microbios 1973; 7:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19048/abstract/35\">",
"      Dougherty JM, McCulley JP, Silvany RE, Meyer DR. The role of tetracycline in chronic blepharitis. Inhibition of lipase production in staphylococci. Invest Ophthalmol Vis Sci 1991; 32:2970.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19048/abstract/36\">",
"      Frucht-Pery J, Sagi E, Hemo I, Ever-Hadani P. Efficacy of doxycycline and tetracycline in ocular rosacea. Am J Ophthalmol 1993; 116:88.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19048/abstract/37\">",
"      Iovieno A, Lambiase A, Micera A, et al. In vivo characterization of doxycycline effects on tear metalloproteinases in patients with chronic blepharitis. Eur J Ophthalmol 2009; 19:708.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19048/abstract/38\">",
"      Igami TZ, Holzchuh R, Osaki TH, et al. Oral azithromycin for treatment of posterior blepharitis. Cornea 2011; 30:1145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19048/abstract/39\">",
"      Torkildsen GL, Cockrum P, Meier E, et al. Evaluation of clinical efficacy and safety of tobramycin/dexamethasone ophthalmic suspension 0.3%/0.05% compared to azithromycin ophthalmic solution 1% in the treatment of moderate to severe acute blepharitis/blepharoconjunctivitis. Curr Med Res Opin 2011; 27:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19048/abstract/40\">",
"      Browning DJ, Proia AD. Ocular rosacea. Surv Ophthalmol 1986; 31:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19048/abstract/41\">",
"      Rubin M, Rao SN. Efficacy of topical cyclosporin 0.05% in the treatment of posterior blepharitis. J Ocul Pharmacol Ther 2006; 22:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19048/abstract/42\">",
"      Perry HD, Doshi-Carnevale S, Donnenfeld ED, et al. Efficacy of commercially available topical cyclosporine A 0.05% in the treatment of meibomian gland dysfunction. Cornea 2006; 25:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19048/abstract/43\">",
"      Lane SS, DuBiner HB, Epstein RJ, et al. A new system, the LipiFlow, for the treatment of meibomian gland dysfunction. Cornea 2012; 31:396.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19048/abstract/44\">",
"      Cohen EJ. Cornea and external disease in the new millennium. Arch Ophthalmol 2000; 118:979.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19048/abstract/45\">",
"      Joseph MA, Kaufman HE, Insler M. Topical tacrolimus ointment for treatment of refractory anterior segment inflammatory disorders. Cornea 2005; 24:417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19048/abstract/46\">",
"      McCulley JP, Shine WE. Changing concepts in the diagnosis and management of blepharitis. Cornea 2000; 19:650.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19048/abstract/47\">",
"      Brownstein S, Codere F, Jackson WB. Masquerade syndrome. Ophthalmology 1980; 87:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19048/abstract/48\">",
"      Akpek EK, Polcharoen W, Chan R, Foster CS. Ocular surface neoplasia masquerading as chronic blepharoconjunctivitis. Cornea 1999; 18:282.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19048/abstract/49\">",
"      Kass LG, Hornblass A. Sebaceous carcinoma of the ocular adnexa. Surv Ophthalmol 1989; 33:477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19048/abstract/50\">",
"      Shields JA, Demirci H, Marr BP, et al. Sebaceous carcinoma of the eyelids: personal experience with 60 cases. Ophthalmology 2004; 111:2151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19048/abstract/51\">",
"      Mamalis N, Kearsley L, Brinton E. Postoperative endophthalmitis. Curr Opin Ophthalmol 2002; 13:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19048/abstract/52\">",
"      Viswalingam M, Rauz S, Morlet N, Dart JK. Blepharokeratoconjunctivitis in children: diagnosis and treatment. Br J Ophthalmol 2005; 89:400.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19048/abstract/53\">",
"      Doan S, Gabison EE, Nghiem-Buffet S, et al. Long-term visual outcome of childhood blepharokeratoconjunctivitis. Am J Ophthalmol 2007; 143:528.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19048/abstract/54\">",
"      Raskin EM, Speaker MG, Laibson PR. Blepharitis. Infect Dis Clin North Am 1992; 6:777.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19048/abstract/55\">",
"      Roth AM. Demodex folliculorum in hair follicles of eyelid skin. Ann Ophthalmol 1979; 11:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19048/abstract/56\">",
"      Kemal M, S&uuml;mer Z, Toker MI, et al. The Prevalence of Demodex folliculorum in blepharitis patients and the normal population. Ophthalmic Epidemiol 2005; 12:287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19048/abstract/57\">",
"      Holzchuh FG, Hida RY, Moscovici BK, et al. Clinical treatment of ocular Demodex folliculorum by systemic ivermectin. Am J Ophthalmol 2011; 151:1030.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6915 Version 12.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-122.72.76.133-AC55A795B2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_38_19048=[""].join("\n");
var outline_f18_38_19048=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H37\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLASSIFICATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Anterior blepharitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Posterior blepharitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      PATHOPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Anterior blepharitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Posterior blepharitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      CLINICAL PRESENTATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      CLINICAL EXAMINATION AND DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      External examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Slit lamp examination",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Eyelids",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Conjunctiva",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Tear film",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Cornea",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      ASSOCIATED OCULAR CONDITIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Hordeolum",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Chalazion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Dry eye",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Contact lens intolerance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Warm compresses",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Lid massage",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Lid washing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Antibiotics",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      - Topical antibiotics",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      - Oral antibiotics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Topical glucocorticoids",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Topical cyclosporine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27856499\">",
"      Thermal pulsation systems",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Future treatments",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      SPECIAL CASES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      Unilateral symptoms and possible malignancy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      Preoperative patients",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      Pediatric blepharitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H35\">",
"      Allergic blepharitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H36\">",
"      Demodex folliculorum",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H37\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PC/6915\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/6915|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?28/6/28771\" title=\"picture 1\">",
"      Anterior blepharitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?25/60/26562\" title=\"picture 2\">",
"      Posterior blepharitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?41/61/42964\" title=\"picture 3\">",
"      Entropion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?19/16/19714\" title=\"picture 4\">",
"      Ectropion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?24/10/24736\" title=\"picture 5\">",
"      Plugged glands",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?9/30/9711\" title=\"picture 6\">",
"      Corneal pannus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?2/54/2916\" title=\"picture 7\">",
"      Hordeolum stye",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?23/30/24034\" title=\"picture 8\">",
"      Chalazion 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?17/19/17714\" title=\"picture 9\">",
"      Severe dry eye",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?10/8/10370\" title=\"picture 10\">",
"      Sebac cell ca",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/11/25784?source=related_link\">",
"      Dry eyes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/63/4088?source=related_link\">",
"      Eyelid lesions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/40/3721?source=related_link\">",
"      Overview of dermatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?30/29/31185?source=related_link\">",
"      Patient information: Blepharitis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?17/56/18305?source=related_link\">",
"      Patient information: Chalazion (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?33/39/34417?source=related_link\">",
"      Patient information: Stye (hordeolum) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/46/36584?source=related_link\">",
"      Rosacea: Pathogenesis, clinical features, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/28/21961?source=related_link\">",
"      Seborrheic dermatitis in adolescents and adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f18_38_19049="Keratosis follicularis spinulosa decalvans";
var content_f18_38_19049=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F87486%7EDERM%2F87487&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F87486%7EDERM%2F87487&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 596px\">",
"   <div class=\"ttl\">",
"    Keratosis follicularis spinulosa decalvans",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 576px; height: 432px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Cicatricial alopecia and follicular keratotic papules are features of keratosis follicularis spinulosa decalvans.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Keratosis follicularis spinulosa decalvans",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 576px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Numerous, small keratotic follicular papules and cicatricial (scarring) alopecia involving the eyebrow are present.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_38_19049=[""].join("\n");
var outline_f18_38_19049=null;
var title_f18_38_19050="Etiology of hearing impairment in children";
var content_f18_38_19050=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Etiology of hearing impairment in children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/38/19050/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/38/19050/contributors\">",
"     Richard JH Smith, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/38/19050/contributors\">",
"     Adrian Gooi, MD, FRCS(C)",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/38/19050/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/38/19050/contributors\">",
"     Glenn C Isaacson, MD, FAAP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/38/19050/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/38/19050/contributors\">",
"     Elizabeth TePas, MD, MS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?18/38/19050/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 23, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hearing loss in the first years of life can cause delays in speech, language, and cognitive development [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/1\">",
"     1",
"    </a>",
"    ]. Speech and language delays secondary to hearing loss are often preventable [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. Thus, early identification of hearing impairment, whether it is permanent (usually sensorineural) or temporary (usually conductive), is the key to a child's success with communication [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/1,3\">",
"     1,3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Significant hearing loss occurs in one to two per 1000 newborns and in two per 1000 young children. However, nearly all children develop transient hearing loss related to middle ear infections during the period from birth to 11 years of age [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/4\">",
"     4",
"    </a>",
"    ]. Knowledge of the etiology of the hearing loss, particularly if genetic, can affect family planning and assist in the development of the optimal habilitation plan for the patient [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/2,5-8\">",
"     2,5-8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The anatomy and physiology of the ear and the etiology of hearing impairment in children are reviewed here. The evaluation and treatment of hearing impairment are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/19/44344?source=see_link\">",
"     \"Evaluation of hearing impairment in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/14/29927?source=see_link\">",
"     \"Treatment of hearing impairment in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ANATOMY AND PHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The ear is divided into three anatomic segments (",
"    <a class=\"graphic graphic_figure graphicRef57082 \" href=\"UTD.htm?33/19/34103\">",
"     figure 1",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The outer ear, comprising the auricle and external auditory canal",
"     </li>",
"     <li>",
"      The middle ear, comprising the tympanic membrane, ossicles, and the middle ear space",
"     </li>",
"     <li>",
"      The inner ear, comprising the cochlea, semicircular canals, and internal auditory canals",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Anatomically, the auricle has a unique structure. It \"catches\" incoming sound waves and then funnels them down the external auditory canal. Sound waves vibrate the tympanic membrane, causing motion of the ossicles that results in a piston-like effect on the stapes. Stapedial motion is transmitted to the inner ear fluid as a traveling wave that propagates around the two and one-half turns of the cochlea. Frequency-specific movement of the organ of Corti bends the stereocilia, causing depolarization of the inner hair cells and creating electrical impulses transmitted via the auditory nerve to the brain. The brain organizes the information into what we perceive as complex sounds.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CLASSIFICATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hearing loss may be classified as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Conductive, involving any cause that in some way limits the amount of external sound that gains access to the inner ear.",
"     </li>",
"     <li>",
"      Sensorineural, involving the inner ear, cochlea, or the auditory nerve.",
"     </li>",
"     <li>",
"      Mixed, which is a combination of conductive and sensorineural hearing loss.",
"     </li>",
"     <li>",
"      Central (involving higher brain centers) and auditory dyssynchrony (also called auditory neuropathy or auditory neuropathy spectrum disorder).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Numerous abnormalities can lead to hearing loss of each type (",
"    <a class=\"graphic graphic_table graphicRef53903 \" href=\"UTD.htm?4/62/5101\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CONDUCTIVE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Conductive losses imply a mechanical problem in the outer or middle ear: the pinna, external canal, tympanic membrane, or ossicles. Examples include cerumen impaction, middle ear fluid, and ossicular chain fixation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Outer ear",
"    </span>",
"    &nbsp;&mdash;&nbsp;Congenital anomalies, infections, and trauma to the outer ear can cause conductive hearing loss.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Congenital",
"    </span>",
"    &nbsp;&mdash;&nbsp;The external auditory canal (EAC) develops from the 8th to the 28th week of gestation; problems can occur anytime during this developmental phase. Microtia, the absence or malformation of the auricle, may be associated with mild-to-moderate conductive hearing loss, whereas atresia or significant stenosis of the EAC causes moderate-to-maximal (60 dB) conductive hearing loss.",
"   </p>",
"   <p>",
"    The auricle itself forms from remnants of the first and second branchial arches during the 12th to 20th weeks of gestation. Thus, it is possible to have a normal auricle but an atretic canal. Unilateral atresia or significant stenosis of the EAC is much more common than is bilateral atresia.",
"   </p>",
"   <p>",
"    Atresia malformations of the EAC occur in approximately 1 per 10,000 births and are often associated with other craniofacial abnormalities such as Treacher-Collins syndrome, Robin sequence, or hemifacial microsomia (Goldenhar spectrum) (",
"    <a class=\"graphic graphic_table graphicRef66758 \" href=\"UTD.htm?12/21/12638\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/59/1977?source=see_link\">",
"     \"Congenital anomalies of the jaw, mouth, oral cavity, and pharynx\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/18/8487?source=see_link\">",
"     \"Craniosynostosis syndromes\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1687404\">",
"    <span class=\"h3\">",
"     Obstruction",
"    </span>",
"    &nbsp;&mdash;&nbsp;The EAC may be obstructed by cerumen or by bony growths such as osteomas or exostoses. Thus, it is important to clear the EAC of cerumen for accurate pediatric audiologic testing. Osteomas are benign solitary smooth-round osseous lesions occurring at the tympanosquamous and tympanomastoid suture lines inside the bony EAC. These lesions usually present in middle age, although they may also occur in children. Exostoses are benign broad-based osseous lesions often presenting after a history of chronic cold water exposure (eg, cold water swimming). These lesions are often multiple and bilateral, are usually diagnosed in teenagers or young adults, and are far more common in males.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infections can lead to blockage of the EAC caused by the accumulation of debris, edema, or inflammation. Otitis externa can develop after local EAC trauma or impacted cerumen becomes contaminated by bacteria (or occasionally fungi) after swimming, showering, or exposure to hot and humid conditions. The canal is often filled with squamous and purulent debris and significant edema of the EAC occurs. The most common symptoms are otalgia (often severe), pruritus, discharge, and hearing loss. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/62/32743?source=see_link\">",
"     \"External otitis: Pathogenesis, clinical features, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Trauma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Penetrating trauma to the EAC or meatus caused by a bullet, knife, or fracture may cause mild to severe conductive hearing loss, depending upon the degree of EAC injury and occlusion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Middle ear",
"    </span>",
"    &nbsp;&mdash;&nbsp;Conductive hearing loss associated with the middle ear may be caused by infection, congenital anomalies, tympanic membrane perforation, or tumors.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Congenital",
"    </span>",
"    &nbsp;&mdash;&nbsp;Abnormalities of the ossicular chain are often congenital and may or may not be associated with EAC",
"    <span class=\"nowrap\">",
"     stenosis/atresia",
"    </span>",
"    or varying degrees of auricular microtia or atresia. The most common congenital ossicular abnormality is absence or malalignment of the crura of the stapes. However, abnormality of the incus or malleoincudal joint is the most consistently identified cause of conductive hearing loss. Other malformations of the ossicular chain include fixation of the malleoincudal joint or one of the ossicles to the scutal or attic ridge. Fracture or dislocation of the ossicular chain or erosion of the ossicular chain by cholesteatoma or chronic suppurative otitis media can also cause conductive hearing loss.",
"   </p>",
"   <p>",
"    Osteogenesis imperfecta is an autosomal dominant condition associated with fragile bones that fracture easily. Children with this disorder may develop ossicular dislocation, stapes fixation, or fracture of the ossicles, resulting in a conductive hearing loss. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/9/38040?source=see_link\">",
"     \"Osteogenesis imperfecta: Clinical features and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Otitis media (OM) is the most common childhood disorder associated with conductive hearing loss. By the age of three years, 83 percent of children will experience at least one episode of OM, and 46 percent will have at least three episodes [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/11\">",
"     11",
"    </a>",
"    ]. About 3 to 20 percent of children have six episodes of OM in a year [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Acute OM is defined as fluid in the middle ear accompanied by signs or symptoms of ear infection: pain, fever, ear fullness,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    decreased hearing. Conductive hearing loss occurs because fluid filling the middle ear space prevents the tympanic membrane from vibrating adequately, thereby diminishing movement of the ossicular chain. The hearing loss persists as long as fluid fills the middle ear space. The median loss is 25 dB, which is similar to putting plugs in the child's ears. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/60/29642?source=see_link&amp;anchor=H22228262#H22228262\">",
"     \"Acute otitis media in children: Epidemiology, microbiology, clinical manifestations, and complications\", section on 'Hearing loss'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Despite adequate therapy, middle ear effusion persists in many patients. Persistence of asymptomatic effusion following an episode of acute otitis media is 40 percent at one month, 20 percent at two months, and 10 percent at three months [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]. Some of the 10 to 15 percent of children in whom the fluid does not clear may benefit from tympanostomy tube placement with or without adenoidectomy to promote healing and resolution of conductive hearing loss [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/15\">",
"     15",
"    </a>",
"    ]. Small, retrospective, case-control, and longitudinal cohort studies have noted that children who have prolonged middle ear effusion have lower scores on tests of speech, language, and cognitive abilities [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/16-18\">",
"     16-18",
"    </a>",
"    ]. However, a study in which children with persistent middle ear effusion were randomly assigned to prompt or delayed insertion of tympanostomy tubes found that developmental outcome at 3, 4, 6, and 9 to 11 years of age did not differ between the groups [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/19-23\">",
"     19-23",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/56/3978?source=see_link&amp;anchor=H8#H8\">",
"     \"Overview of tympanostomy tube placement and medical care of children with tympanostomy tubes\", section on 'Indications for tubes'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/40/22153?source=see_link\">",
"     \"Otitis media with effusion (serous otitis media) in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     TM perforation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Conductive hearing loss caused by tympanic membrane perforation is common. The degree of conductive hearing loss depends upon the size and location of the perforation. Small perforations and those located in the",
"    <span class=\"nowrap\">",
"     anterior/inferior",
"    </span>",
"    quadrant cause a lesser degree of conductive hearing loss; near total or",
"    <span class=\"nowrap\">",
"     posterior/superior",
"    </span>",
"    quadrant perforations are more likely to cause significant hearing loss.",
"   </p>",
"   <p>",
"    Tympanic membrane perforations can be caused by many events, including blast injury, barotrauma, foreign body trauma, temporal bone fractures, ear infections, self-inflicted trauma from a Q-tip or other object (",
"    <a class=\"graphic graphic_picture graphicRef67932 \" href=\"UTD.htm?15/32/15874\">",
"     picture 1",
"    </a>",
"    ), or the hole may persist after tympanostomy tubes fall out. After an acute perforation, the ear needs to be examined to ensure that the perforation heals without cholesteatoma formation. Documentation of a patient's auditory status also is mandatory for any newly diagnosed perforation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/51/42808?source=see_link\">",
"     \"Cholesteatoma in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Trauma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Blunt trauma can lead to temporal bone fracture, usually by a blow to the temporal parietal region (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef59595 \" href=\"UTD.htm?27/60/28610\">",
"     image 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/24\">",
"     24",
"    </a>",
"    ]. The traditional classification system divided temporal bone fractures into longitudinal (more common at 80 percent) or transverse (more often associated with sensorineural hearing loss), relative to the petrous apex. However, the current classification of temporal bone fractures focuses on whether the otic capsule is spared or violated. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/29/5593?source=see_link\">",
"     \"Evaluation and management of middle ear trauma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Hearing loss due to temporal bone fracture is typically conductive and associated with tympanic membrane perforations and blood in the middle ear space. Conductive hearing loss can occur with ossicular injury, typically due to separation of the incudal stapedial joint",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    incus dislocation. Otic capsule violating fractures are more frequently associated with sensorineural hearing loss, facial nerve injury, or cerebrospinal fluid leak. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'Sensorineural'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Tumors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Malignant tumors such as squamous cell carcinoma and proliferative disorders, including Langerhans cell histiocytosis can cause conductive hearing loss. However, these entities are relatively rare when compared with nonmalignant cholesteatoma or otosclerosis.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cholesteatoma &mdash; Cholesteatoma is a benign growth of stratified, squamous epithelium filled with desquamated cells and keratin (",
"      <a class=\"graphic graphic_picture graphicRef80406 \" href=\"UTD.htm?2/27/2481\">",
"       picture 2",
"      </a>",
"      ). As keratin desquamates from the epithelial lining of the sac, it gradually enlarges, with eventual erosion of the ossicular chain, mastoid air cells, and EAC. Formation of a cholesteatoma typically occurs after a retraction pocket has formed in the",
"      <span class=\"nowrap\">",
"       posterior/superior",
"      </span>",
"      quadrant, usually the result of poor eustachian tube function. It may also occur after tympanic membrane trauma, such as a traumatic, inflammatory, or iatrogenic perforation. A small percentage of cholesteatomas are congenital and occur most commonly in the anterior superior portion of the middle ear space. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/51/42808?source=see_link\">",
"       \"Cholesteatoma in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Otosclerosis &mdash; Otosclerosis is an abnormality of bone remodeling that produces overgrowth of sclerotic, hypervascular bone. It has a predilection for the footplate of the stapes. As the overgrowth develops, stapes motion is impaired and ossicular vibrations are not effectively transmitted to the inner ear fluid. Conduction gradually becomes worse until a maximal conductive hearing loss of 60 dB is reached. The long-term prognosis (several decades) includes the development of a significant sensorineural component to the hearing loss in the majority of persons with otosclerosis. Otosclerosis is uncommon in children and very rarely recognized in the first decade of life.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     SENSORINEURAL",
"    </span>",
"    &nbsp;&mdash;&nbsp;Disorders of the inner ear cause sensorineural hearing loss (SNHL). Problems may occur at the level of the cochlea, eighth nerve, internal auditory canal, or brain.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Congenital",
"    </span>",
"    &nbsp;&mdash;&nbsp;Congenital hearing loss is any hearing loss that is identified at or shortly after birth; it may be hereditary or nonhereditary. Nonhereditary etiologies involve an insult to the developing cochlea, such as intrauterine infection, medications, or toxins that have a teratogenic effect on the developing ear of the fetus (eg, alcohol, methyl mercury,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?19/12/19655?source=see_link\">",
"     quinine",
"    </a>",
"    , trimethadione, retinoic acid, and maternal thyroid peroxidase autoantibodies) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/8,25\">",
"     8,25",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Congenital infection caused by cytomegalovirus (CMV), toxoplasmosis, rubella, or syphilis is associated with SNHL. The hearing loss in these conditions frequently is progressive or delayed in onset, emphasizing the need for universal newborn hearing screening and continued monitoring of children with known congenital infections. The US Preventive Services Task Force (USPSTF) clinical practice guideline for newborn hearing screening, as well as other USPSTF guidelines, can be accessed through the website for the Agency for Healthcare Research and Quality at",
"    <a class=\"external\" href=\"file://www.ahrq.gov/clinic/uspstfix.htm\">",
"     www.ahrq.gov/clinic/uspstfix.htm",
"    </a>",
"    . (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/13/43225?source=see_link&amp;anchor=H9#H9\">",
"     \"Screening tests in children and adolescents\", section on 'Hearing screen'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/13/27865?source=see_link\">",
"     \"Screening the newborn for hearing loss\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Congenital cytomegalovirus infection &mdash; Congenital CMV is the most common intrauterine infection in humans as well as the leading infectious cause of congenital sensorineural deafness [",
"      <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/26-29\">",
"       26-29",
"      </a>",
"      ]. Forty thousand infants in the United States are born each year with congenital CMV; 90 percent are asymptomatic. Among the 10 percent who are symptomatic, approximately 60 percent develop SNHL [",
"      <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/30\">",
"       30",
"      </a>",
"      ]. Even among asymptomatic children with documented CMV infection in one study, 7 percent developed SNHL [",
"      <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/31\">",
"       31",
"      </a>",
"      ]. The hearing loss was progressive in 50 percent and delayed in onset (median age 27 months) in 18 percent. It can be either unilateral or bilateral. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/24/28041?source=see_link&amp;anchor=H29#H29\">",
"       \"Overview of TORCH infections\", section on 'Congenital cytomegalovirus'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/51/36664?source=see_link\">",
"       \"Cytomegalovirus infection and disease in newborns, infants, children and adolescents\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Congenital toxoplasmosis &mdash; Congenital toxoplasmosis occurs in one in 1000 to 8000 births. Ninety percent of the cases are asymptomatic at birth. SNHL can occur in these children, although the exact incidence is unclear [",
"      <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/32\">",
"       32",
"      </a>",
"      ]. The hearing loss can be delayed and progressive [",
"      <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/33\">",
"       33",
"      </a>",
"      ]. The hearing loss may be prevented by treatment with",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?7/50/7973?source=see_link\">",
"       pyrimethamine",
"      </a>",
"      and sulfonamide preparations if the infection is diagnosed prenatally or shortly after birth [",
"      <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/32\">",
"       32",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/24/28041?source=see_link&amp;anchor=H7#H7\">",
"       \"Overview of TORCH infections\", section on 'Congenital toxoplasmosis'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/12/43208?source=see_link&amp;anchor=H11763926#H11763926\">",
"       \"Congenital toxoplasmosis: Clinical features and diagnosis\", section on 'Clinical features'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Congenital rubella &mdash; Although the incidence of congenital rubella has declined by more than 99 percent since the introduction of the rubella vaccine in 1969 [",
"      <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/34\">",
"       34",
"      </a>",
"      ], approximately 5 to 25 percent of women of child-bearing age remain susceptible to rubella infection [",
"      <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/35\">",
"       35",
"      </a>",
"      ]. Hearing loss affects 68 to 93 percent of children with congenital rubella; it is usually profound and bilateral and sometimes progressive [",
"      <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/8\">",
"       8",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/49/10010?source=see_link\">",
"       \"Congenital rubella syndrome: Clinical features and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Congenital syphilis &mdash; The incidence of congenital syphilis, which is approximately 0.005 percent of live births in the United States, has been increasing steadily since 1985. One-third to two-thirds of infected infants are asymptomatic at birth [",
"      <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/8,35\">",
"       8,35",
"      </a>",
"      ]. SNHL, which occurs in 30 to 40 percent of these infants, is a late manifestation of congenital syphilis and appears after two years of age. It is the result of inflammation from untreated disease and can be prevented by appropriate therapy before three months of age [",
"      <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/8,35\">",
"       8,35",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/31/17914?source=see_link&amp;anchor=H28809349#H28809349\">",
"       \"Congenital syphilis: Clinical features and diagnosis\", section on 'Late congenital syphilis'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Malformations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Congenital malformations (dysplasias) of the inner ear cause SNHL. Temporal bone studies in the 1800s described four general types:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Michel &mdash; complete lack of inner ear",
"     </li>",
"     <li>",
"      Mondini &mdash; incomplete development and malformation of the inner ear",
"     </li>",
"     <li>",
"      Scheibe &mdash; membranous cochleosaccular degeneration of the inner ear",
"     </li>",
"     <li>",
"      Alexander &mdash; malformation of the cochlear membranous system",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Modern computed tomographic and magnetic resonance imaging studies have identified more subtle variations in anatomy that my lead to variable degrees of hearing loss. As an example, cochlear nerve canal stenosis was associated with SNHL in one retrospective review, and the degree of stenosis correlated with the severity of hearing loss [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/36\">",
"     36",
"    </a>",
"    ]. Genetic counseling is recommended for the parents, as well as for the child, since inner ear abnormalities may be associated with other abnormalities or may be hereditary. Diagnostic considerations should include complete audiometric evaluation, complete otolaryngologic evaluation, and proper diagnostic imaging studies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Perilymph fistula",
"    </span>",
"    &nbsp;&mdash;&nbsp;Perilymph fistula (PLF) is a leak of inner ear fluid through a defect in the otic capsule. Leaks at the round window membrane or the oval window annular ligament may occur. PLFs permit communication between the middle ear and the inner ear. They can be caused by trauma or by a congenital defect of the stapes footplate.",
"   </p>",
"   <p>",
"    PLF is uncommon and difficult to diagnose. Typical symptoms include fluctuating severe SNHL, dysequilibrium, and aural fullness. Exploratory surgery performed by an otolaryngologist may be necessary to provide a definite diagnosis and to repair the leak.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Hereditary",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hereditary (genetic) bilateral SNHL occurs in about 1 in 2000 births [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/4\">",
"     4",
"    </a>",
"    ]. Genetic causes of SNHL account for up to 50 percent of cases of SNHL and include SNHL with (one-third) and without (two-thirds) associated abnormalities (syndromic and nonsyndromic, respectively) (",
"    <a class=\"graphic graphic_table graphicRef66758 \" href=\"UTD.htm?12/21/12638\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/37,38\">",
"     37,38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The hearing deficit in hereditary hearing impairment (HHI) may be present at birth (congenital), progressive from birth, or it may develop when the child is older.",
"   </p>",
"   <p>",
"    Approximately 80 percent of cases of HHI are inherited in an autosomal recessive pattern, 15 percent are autosomal dominant, 2 percent are X-linked (mainly recessive) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/39\">",
"     39",
"    </a>",
"    ], and 1 percent are mitochondrial [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Autosomal recessive",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because HHI is most often inherited as an autosomal recessive trait, many children with HHI will not have affected relatives. There are both syndromic and nonsyndromic forms of HHI. Among the more common syndromic autosomal recessive disorders are Usher syndrome, Pendred syndrome, Alport syndrome, and Jervell-Lange-Nielsen syndrome (long QT syndrome with deafness). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/9/2202?source=see_link&amp;anchor=H21#H21\">",
"     \"Clinical features of congenital long QT syndrome\", section on 'Congenital sensorineural deafness'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/27/19896?source=see_link\">",
"     \"Retinitis pigmentosa: Clinical presentation and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/45/24280?source=see_link&amp;anchor=H4#H4\">",
"     \"Congenital and acquired goiter in children\", section on 'Inborn errors of thyroid hormone production'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/33/36377?source=see_link\">",
"     \"Clinical manifestations, diagnosis and treatment of hereditary nephritis (Alport syndrome)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Advances are being made in the understanding of the molecular biology of hearing [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/40-44\">",
"     40-44",
"    </a>",
"    ]. As examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Autosomal recessive Alport syndrome is associated with mutations in the alpha-3 or alpha-4 chains of type IV collagen [",
"      <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/45\">",
"       45",
"      </a>",
"      ]. The defect in hearing, as well as the associated renal disease, is caused by impaired formation of a unique type of collagen. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/5/24663?source=see_link\">",
"       \"Genetics, pathogenesis, and pathology of hereditary nephritis (Alport syndrome)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Over 80 distinct loci have been linked with nonsyndromic recessive hearing loss [",
"      <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/46,47\">",
"       46,47",
"      </a>",
"      ]. Mutations in the GJB2 gene that encodes the protein connexin 26 (CX26) on chromosome 13 cause approximately half of all bilateral moderate-to-profound congenital hearing loss in nonsyndromic children [",
"      <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/38,42,48,49\">",
"       38,42,48,49",
"      </a>",
"      ]. Mutations in this gene are also an occasional cause of autosomal dominant hearing loss that is often associated with palmoplantar keratoderma [",
"      <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/50,51\">",
"       50,51",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The defect in Jervell-Lange-Nielsen syndrome, which typically presents with bilateral profound SNHL and long QT on electrocardiogram, involves potassium conductance and impaired endolymph production [",
"      <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/52\">",
"       52",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/0/28681?source=see_link\">",
"       \"Genetics of congenital and acquired long QT syndrome\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These advances are improving our understanding of the biology of hearing and deafness. The evaluation and management of the hearing-impaired child are starting to change as more comprehensive genetic testing for HHI is becoming available.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Autosomal dominant",
"    </span>",
"    &nbsp;&mdash;&nbsp;Waardenburg syndrome types I and II (",
"    <a class=\"graphic graphic_picture graphicRef56776 \" href=\"UTD.htm?33/18/34084\">",
"     picture 3",
"    </a>",
"    ), neurofibromatosis I and II, and branchio-oto-renal syndrome are examples of common autosomal dominant disorders that cause syndromic SNHL. Conductive, sensorineural, or mixed hearing loss is also common in patients with velocardiofacial and Williams syndromes [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/53\">",
"     53",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/0/24586?source=see_link&amp;anchor=H24#H24\">",
"     \"The genodermatoses\", section on 'Waardenburg syndrome'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/50/36650?source=see_link\">",
"     \"Neurofibromatosis type 1 (von Recklinghausen's disease)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/14/20712?source=see_link\">",
"     \"Neurofibromatosis type 2\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/49/12055?source=see_link\">",
"     \"Congenital anomalies of the ear\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/43/10935?source=see_link&amp;anchor=H12#H12\">",
"     \"Renal hypoplasia\", section on 'Branchio-oto-renal syndrome'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/15/250?source=see_link&amp;anchor=H15#H15\">",
"     \"Syndromes with craniofacial abnormalities\", section on 'Velocardiofacial (Shprintzen) syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Nonsyndromic autosomal dominant disorders that cause progressive SNHL may present with early onset (during the first decade of life) or delayed onset (during the second or third decade) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/37\">",
"     37",
"    </a>",
"    ]. Over 60 loci have been mapped and over 25 genes have been implicated in this type of hearing loss.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     X-linked",
"    </span>",
"    &nbsp;&mdash;&nbsp;Among the X-linked disorders associated with SNHL are Hunter syndrome (mucopolysaccharidosis 2), Alport syndrome, X-linked congenital SNHL, and early onset progressive sensorineural hearing loss [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/4,46,54\">",
"     4,46,54",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/6/7274?source=see_link&amp;anchor=H8#H8\">",
"     \"Clinical features and diagnosis of the mucopolysaccharidoses\", section on 'MPS type II (Hunter syndrome)'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/33/36377?source=see_link\">",
"     \"Clinical manifestations, diagnosis and treatment of hereditary nephritis (Alport syndrome)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Mitochondrial",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mitochondrial inheritance accounts for less than 1 percent of all HHI. Transmission occurs through the maternal lineage. Hearing loss may be isolated or associated with other features of mitochondrial disorders: lactic acidosis, encephalopathy, myopathy, seizures, ophthalmoplegia, diabetes mellitus, cardiomyopathy, stroke-like episodes, ataxia, and optic atrophy [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/46\">",
"     46",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/56/905?source=see_link\">",
"     \"Approach to the metabolic myopathies\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Acquired SNHL",
"    </span>",
"    &nbsp;&mdash;&nbsp;Causes of acquired SNHL include prematurity, infection, hyperbilirubinemia, ototoxins, noise, and tumors.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h3\">",
"     Prematurity",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prevalence of congenital SNHL among babies with low birth weight (less than 1500 g) is 51 per 10,000 [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/55\">",
"     55",
"    </a>",
"    ]. The high rate of hearing loss among these children has been linked to several factors, including administration of ototoxic drugs such as aminoglycoside antibiotics, ambient noise produced by the incubator [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/56\">",
"     56",
"    </a>",
"    ], and perinatal complications (eg, hypoxia, acidosis, and hyperbilirubinemia) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/57,58\">",
"     57,58",
"    </a>",
"    ]. Continued improvements in obstetrical and newborn care have led to decreased mortality in premature infants. As further advances are made in this area, decreased mortality will pose an increased risk of developmental disabilities, including hearing loss, for premature and low-birth-weight babies [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/59,60\">",
"     59,60",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/29/11738?source=see_link&amp;anchor=H10#H10\">",
"     \"Care of the neonatal intensive care unit graduate\", section on 'Hearing'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although the majority of neonates admitted to the neonatal intensive care unit (NICU) meet the high-risk requirement for hearing screening, universal newborn hearing screening is necessary to detect hearing loss among those without obvious risk factors. The USPSTF clinical practice guideline for newborn hearing screening, as well as other USPSTF guidelines, can be accessed through the website for the Agency for Healthcare Research and Quality at",
"    <a class=\"external\" href=\"file://www.ahrq.gov/clinic/uspstfix.htm\">",
"     www.ahrq.gov/clinic/uspstfix.htm",
"    </a>",
"    . (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/13/27865?source=see_link\">",
"     \"Screening the newborn for hearing loss\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h3\">",
"     Hyperbilirubinemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hyperbilirubinemia in infants is frequently caused by hemolysis. Causes of hemolysis include Rh or ABO blood group incompatibility and glucose-6-phosphate-dehydrogenase deficiency. Hyperbilirubinemia, which can also result from other newborn complications, including sepsis and immature liver function, leads to sensorineural hearing loss because bilirubin is toxic to the cochlear nuclei and the central auditory pathways (auditory neuropathy). Information about auditory neuropathy can be accessed through the website for the US National Institute on Deafness and Other Communication Disorders (NIDCD) at",
"    <a class=\"external\" href=\"file://www.nidcd.nih.gov/health/hearing/neuropathy.htm\">",
"     file://www.nidcd.nih.gov/health/hearing/neuropathy.htm",
"    </a>",
"    . (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/63/25593?source=see_link&amp;anchor=H5#H5\">",
"     \"Clinical manifestations of unconjugated hyperbilirubinemia in term and late preterm infants\", section on 'Kernicterus'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Hyperbilirubinemia may need to be treated with phototherapy or exchange transfusion depending upon a number of factors, including the level of and rate of rise of bilirubin, the gestational age of the infant, and others. The risk of hearing loss is increased in children with prolonged hyperbilirubinemia and adverse perinatal factors, such as acidosis and low birth weight [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/61\">",
"     61",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h3\">",
"     Infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bacterial meningitis is the most common cause of postnatally acquired deafness in childhood [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/62,63\">",
"     62,63",
"    </a>",
"    ]. The reported frequency of persistent hearing impairment varies from 2.5 to 18 percent in survivors [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/62-65\">",
"     62-65",
"    </a>",
"    ]. Another 10 percent of children have transient hearing impairment [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/65\">",
"     65",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/58/31656?source=see_link\">",
"     \"Neurologic complications of bacterial meningitis in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Sensorineural hearing loss occurs early in the course of bacterial meningitis (within the first 48 hours), with possible recovery or worsening during the first two weeks of illness [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/66,67\">",
"     66,67",
"    </a>",
"    ]. Permanent hearing loss may be caused by damage to the cochlea, labyrinth, or eighth cranial nerve from direct bacterial invasion or the inflammatory response elicited by the infection [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/64,68\">",
"     64,68",
"    </a>",
"    ]. Labyrinthitis detected by gadolinium-enhanced MRI early in the course of disease is predictive of the development of SNHL [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/69\">",
"     69",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In some studies, treatment with",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/33/35344?source=see_link\">",
"     dexamethasone",
"    </a>",
"    early in the course of meningitis decreases the incidence of hearing loss and neurologic sequelae. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/35/38458?source=see_link&amp;anchor=H16#H16\">",
"     \"Treatment and prognosis of acute bacterial meningitis in children older than one month of age\", section on 'Use of dexamethasone'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Children who have had bacterial meningitis should have a prompt and complete hearing evaluation initially and regular follow-up if the evaluation is abnormal. These children may be candidates for early cochlear implantation (before the onset of cochlear ossification). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/19/44344?source=see_link\">",
"     \"Evaluation of hearing impairment in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h3\">",
"     Ototoxic drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ototoxic drugs such as aminoglycosides, high dose intravenous loop diuretics, and chemotherapeutic agents such as",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/8/34949?source=see_link\">",
"     cisplatin",
"    </a>",
"    can cause significant hearing loss [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/70,71\">",
"     70,71",
"    </a>",
"    ]. The hearing loss caused by antibiotic or chemotherapeutic agents usually begins at high frequencies. The hearing loss becomes more pronounced with continued use and may even continue to worsen after the drug is discontinued. Any sensorineural hearing loss associated with these drugs is permanent.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Aminoglycosides &mdash; All aminoglycosides are ototoxic. Some are more vestibulotoxic than cochleotoxic. In addition, renal impairment may increase the chance of ototoxicity. The relative order of cochleotoxicity is",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?36/48/37632?source=see_link\">",
"       gentamicin",
"      </a>",
"      &gt;",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?21/39/22129?source=see_link\">",
"       tobramycin",
"      </a>",
"      &gt;",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?12/43/12984?source=see_link\">",
"       amikacin",
"      </a>",
"      &gt;",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?28/42/29348?source=see_link\">",
"       neomycin",
"      </a>",
"      . Individuals with mutations in some of the mitochondrial genes have a genetic predisposition to the development of ototoxicity when exposed to even small doses of aminoglycosides [",
"      <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/72,73\">",
"       72,73",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/41/18072?source=see_link\">",
"       \"Pathogenesis and prevention of aminoglycoside nephrotoxicity and ototoxicity\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Otoacoustic emissions, which reflect the functional status of the outer hair cells in the cochlea, are a sensitive measure of the early effects of aminoglycoside-induced injury to the peripheral auditory system [",
"      <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/74\">",
"       74",
"      </a>",
"      ] and may be useful in monitoring cochlear function during ototoxic treatment.",
"     </li>",
"     <li>",
"      Other antibiotics &mdash; Other antibiotics that can cause ototoxicity include the macrolides (",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/11/38064?source=see_link\">",
"       erythromycin",
"      </a>",
"      ,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?29/37/30297?source=see_link\">",
"       clarithromycin",
"      </a>",
"      , and",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/15/35056?source=see_link\">",
"       azithromycin",
"      </a>",
"      ),",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?22/58/23465?source=see_link\">",
"       vancomycin",
"      </a>",
"      , and",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?27/38/28262?source=see_link\">",
"       tetracycline",
"      </a>",
"      . These drugs may have a more pronounced ototoxic effect in patients with impaired renal function.",
"     </li>",
"     <li>",
"      Chemotherapeutic agents &mdash; Numerous chemotherapeutic agents can cause hearing loss. The most common ones are",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/8/34949?source=see_link\">",
"       cisplatin",
"      </a>",
"      , 5-fluorouracil (5-FU),",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?15/33/15895?source=see_link\">",
"       bleomycin",
"      </a>",
"      , and nitrogen mustard. The worst ototoxicity occurs with cisplatin, which causes hearing impairment in 10 to 26 percent of children who receive it [",
"      <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/75,76\">",
"       75,76",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/23/37242?source=see_link&amp;anchor=H2#H2\">",
"       \"Neurologic complications of platinum-based chemotherapy\", section on 'Cisplatin'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Salicylates &mdash;",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?19/10/19624?source=see_link\">",
"       Aspirin",
"      </a>",
"      and other nonsteroidal antiinflammatory drugs can cause hearing loss that is reversible with discontinuation of the drug. The etiology is believed to be enzymatic inhibition, which occurs only at very high doses (eg, 6 to 8",
"      <span class=\"nowrap\">",
"       g/day",
"      </span>",
"      of aspirin).",
"     </li>",
"     <li>",
"      Other medications &mdash; Antimalarial medications such as",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?19/12/19655?source=see_link\">",
"       quinine",
"      </a>",
"      and",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?39/53/40790?source=see_link\">",
"       chloroquine",
"      </a>",
"      can cause sensorineural hearing loss and tinnitus but, as with salicylates, these effects are usually reversible. High-dose intravenous-loop diuretics are an additional cause of temporary hearing loss and tinnitus [",
"      <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/77\">",
"       77",
"      </a>",
"      ]. The risk is increased if the patient is also receiving other ototoxins such as an aminoglycoside [",
"      <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/71\">",
"       71",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h3\">",
"     Noise exposure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Constant exposure to loud noises, as may occur with personal listening devices [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/78\">",
"     78",
"    </a>",
"    ], can cause high-frequency SNHL. The estimated prevalence of noise-induced hearing loss in one or both ears in United States children aged 6 to 19 years is 12.5 percent, with incidence higher prevalence (19.5 percent) seen in older children aged 12 to 19 years [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/79\">",
"     79",
"    </a>",
"    ]. The figure represents a typical audiogram of noise-induced SNHL (",
"    <a class=\"graphic graphic_figure graphicRef67636 \" href=\"UTD.htm?29/43/30387\">",
"     figure 2",
"    </a>",
"    ). The worst hearing loss is at 4000 Hz; it improves at 8000 Hz. However, this shape will decrease over time as more and more frequencies are involved.",
"   </p>",
"   <p>",
"    The mechanism by which excessive noise induces hearing loss includes direct mechanical damage of cochlear structures and metabolic overload caused by overstimulation [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/80\">",
"     80",
"    </a>",
"    ]. Some potential metabolic effects are excess nitric oxide release, which can damage hair cells; generation of oxygen free radicals that become toxic to membranes; and low magnesium concentrations that weaken hair cells by reducing the concentration of intracellular calcium.",
"   </p>",
"   <p>",
"    The Occupational Safety and Health Administration (OSHA) and National Institute for Occupational Safety and Health (NIOSH) have set standards and guidelines for noise exposure in order to protect workers in the United States. OSHA requires all employees who are exposed to a greater than 85 dB time-weighted average (85 dBA) to be enrolled in a hearing conservation program and provided hearing protection. OSHA also limits employee's exposure to noise as follows: eight hours of exposure to 90 dBA (which is equivalent to the noise made by a power lawn mower); four hours of exposure to 95 dBA; two hours of exposure to 100 dBA; and so on [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/81\">",
"     81",
"    </a>",
"    ]. NIOSH limits noise exposure as follows: eight hours to 85 dBA; four hours to 88 dBA; two hours to 91 dBA; and so on [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/82\">",
"     82",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The OSHA and NIOSH standards are not necessarily applicable to portable music-listening devices, since music differs from industrial noise spectrally and temporally [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/78\">",
"     78",
"    </a>",
"    ]. However, studies documenting the output levels of various portable listening devices (compact disc [CD] players and digital music players) have been used to develop safety guidelines based upon NIOSH standards [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/83,84\">",
"     83,84",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For the typical listener, listening to a portable CD player with supra-aural headphones (earphones that sit on top of the ear) at 60 percent maximum volume should be limited to less than one hour per day in order to reduce the risk of noise-induced hearing loss (NIHL) [",
"      <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/83\">",
"       83",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      For the typical listener, listening to a digital music player with the earphones that came with the device at 70 percent of maximum volume should be limited to less than 4.6 hours per day and at 80 percent of maximum volume should be limited to less than 1.2 hours per day in order to reduce the risk of NIHL [",
"      <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/84\">",
"       84",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The listening times should be adjusted according to presence of other risk factors for hearing loss (eg, ototoxic drugs) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/83\">",
"     83",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A short blast of loud noise also can cause severe to profound SNHL, pain, or hyperacusis (loudness intolerance). This reaction usually involves exposure to noise greater than 120 to 155 dB (eg, an ambulance siren or a firecracker). Thus, hearing protection in the form of muffs or plugs is highly recommended any time a person is exposed to loud noises.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h3\">",
"     Trauma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Trauma to the temporal bone usually causes sensorineural or mixed hearing loss. Both penetrating and blunt trauma can result in transverse temporal bone fractures. Penetrating trauma is typically due to gunshot wounds and blunt trauma to blows to the occipital or frontal regions. Temporal bone fractures which violate the otic capsule may run through the inner ear and result in a \"dead\" ear (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef59595 \" href=\"UTD.htm?27/60/28610\">",
"     image 1",
"    </a>",
"    ). Blunt trauma also causes sensorineural hearing loss when concussive forces are exerted on the inner ear fluids, causing a shearing effect on the cochlear organ of Corti. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/29/5593?source=see_link\">",
"     \"Evaluation and management of middle ear trauma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/24/13704?source=see_link\">",
"     \"Skull fractures in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h3\">",
"     Tumors",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common tumor that causes SNHL is a vestibular schwannoma (acoustic neuroma), which is rare in children without neurofibromatosis type 2. These benign tumors usually originate from the vestibular portion of the eighth cranial nerve. Acoustic neuromas associated with neurofibromatosis type 2 are typically bilateral and asymmetric [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/85\">",
"     85",
"    </a>",
"    ]. Other symptoms and signs include tinnitus, disequilibrium, dizziness, headaches, and facial hyperesthesia, facial muscular twitching, and facial",
"    <span class=\"nowrap\">",
"     paresis/paralysis.",
"    </span>",
"    (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/18/40232?source=see_link\">",
"     \"Vestibular schwannoma (acoustic neuroma)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28805698\">",
"    <span class=\"h3\">",
"     Heavy metals",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cadmium, mercury, and arsenic may have toxic effects on cochlear cells and mercury exposure may cause delayed auditory brainstem evoked potentials [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/86\">",
"     86",
"    </a>",
"    ]. In addition, lead can have neurotoxic effects. In a series of 2535 adolescents aged 12 to 19 years, those with a blood lead level of &ge;2",
"    <span class=\"nowrap\">",
"     ug/dL",
"    </span>",
"    had a twofold increased odds of high-frequency hearing loss compared with those with a lead level &lt;1",
"    <span class=\"nowrap\">",
"     ug/dL",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/87\">",
"     87",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1687470\">",
"    <span class=\"h1\">",
"     CENTRAL",
"    </span>",
"    &nbsp;&mdash;&nbsp;Central auditory processing disorder (CAPD) and auditory dyssynchrony (or auditory neuropathy) are described as a deficit in the perception or complete analysis of auditory information that is associated with dysfunction of the central auditory nervous system (most commonly the cerebral cortex) or auditory nerve [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/88,89\">",
"     88,89",
"    </a>",
"    ]. Central auditory processing occurs after the sensory reception of auditory signals. Auditory dyssynchrony may reflect damage to the inner hair cells of the cochlea or to the auditory nerve or brainstem. Auditory brainstem response testing may show a prominent cochlear microphonic (electrical potential), but absent or severely distorted auditory brainstem responses. Otoacoustic emissions, produced by the outer hair cells, are frequently preserved. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/57/21399?source=see_link&amp;anchor=H24#H24\">",
"     \"Etiology of speech and language disorders in children\", section on 'Central auditory processing disorder'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The CAPD diagnosis is suspected when a parent, caregiver, or teacher expresses concern regarding hearing, language, speech, or child development. Risk factors for either peripheral or central auditory dysfunction include in utero infection, prematurity, bacterial infection, hyperbilirubinemia, asphyxia, head trauma, and other neurologic insults during infancy. It may also occur secondary to structural abnormalities of the inner ear or to genetic causes, including mutations in the otoferlin gene [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/90\">",
"     90",
"    </a>",
"    ]. CAPD should be considered in patients with auditory perceptual problems that are not explained by regular audiologic testing [",
"    <a class=\"abstract\" href=\"UTD.htm?18/38/19050/abstract/91\">",
"     91",
"    </a>",
"    ]. Specialized psychoacoustic testing is often needed to make a definitive diagnosis of a CAPD.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3545487\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Significant hearing loss is uncommon in newborns and young children. However, nearly all children develop transient hearing loss related to ear infections during early childhood. Hearing loss in the first years of life can cause delays in speech, language, and cognitive development. Knowledge of the etiology of the hearing loss, particularly if genetic, can affect family planning and assist in the development of the optimal habilitation plan for the child. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The ear is divided into three segments (",
"      <a class=\"graphic graphic_figure graphicRef57082 \" href=\"UTD.htm?33/19/34103\">",
"       figure 1",
"      </a>",
"      ) (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Anatomy and physiology'",
"      </a>",
"      above.):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      The outer ear, comprising the auricle and ear canal",
"     </li>",
"     <li>",
"      The middle ear, comprising the tympanic membrane, ossicles, and the middle ear space",
"     </li>",
"     <li>",
"      The inner ear, comprising the cochlea, semicircular canals, and internal auditory canals",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hearing loss may be classified as follows (",
"      <a class=\"graphic graphic_table graphicRef53903 \" href=\"UTD.htm?4/62/5101\">",
"       table 1",
"      </a>",
"      ) (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Classification'",
"      </a>",
"      above.):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Conductive, involving any cause that in some way limits the amount of external sound that gains access to the inner ear",
"     </li>",
"     <li>",
"      Sensorineural, involving the inner ear, cochlea, or the auditory nerve",
"     </li>",
"     <li>",
"      Mixed, which is a combination of conductive and sensorineural hearing loss",
"     </li>",
"     <li>",
"      Central (involving higher brain centers) and auditory dyssynchrony",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Conductive losses imply a problem in the outer or middle ear: the pinna, external canal, tympanic membrane, or ossicles. Congenital anomalies, infections, and trauma to the outer ear can cause conductive hearing loss. Conductive hearing loss associated with the middle ear may be caused by congenital anomalies, infection, tympanic membrane perforation, or tumors. Examples of causes of conductive hearing loss include cerumen impaction, middle ear fluid, and ossicular chain fixation. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Conductive'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Disorders of the inner ear cause sensorineural hearing loss (SNHL). Problems may occur at the level of the cochlea, eighth nerve, internal auditory canal, or brain. Congenital hearing loss is any hearing loss that occurs at or shortly after birth; it may be hereditary or nonhereditary. Nonhereditary etiologies involve an insult to the developing cochlea, such as intrauterine infection, medications, or toxins that have a teratogenic effect on the developing ear of the fetus. Hereditary causes account for up to 50 percent of cases of SNHL and include SNHL with (one-third) and without (two-thirds) associated abnormalities (syndromic and nonsyndromic, respectively) (",
"      <a class=\"graphic graphic_table graphicRef66758 \" href=\"UTD.htm?12/21/12638\">",
"       table 2",
"      </a>",
"      ). The hearing deficit in hereditary hearing impairment (HHI) may be present at birth (congenital), progressive from birth, or it may develop when the child is older. Causes of acquired SNHL include prematurity, infection, hyperbilirubinemia, ototoxins, noise, trauma, and tumors. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Sensorineural'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Central auditory processing disorder (CAPD) is described as a deficit in the perception or complete analysis of auditory information that is associated with dysfunction of the central auditory nervous system, most commonly the cerebral cortex. It occurs after the sensory reception of auditory signals, but prior to language processing or comprehension. (See",
"      <a class=\"local\" href=\"#H1687470\">",
"       'Central'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/1\">",
"      Kral A, O'Donoghue GM. Profound deafness in childhood. N Engl J Med 2010; 363:1438.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/2\">",
"      Yoshinaga-Itano C, Sedey AL, Coulter DK, Mehl AL. Language of early- and later-identified children with hearing loss. Pediatrics 1998; 102:1161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/3\">",
"      Downs MP, Yoshinaga-Itano C. The efficacy of early identification and intervention for children with hearing impairment. Pediatr Clin North Am 1999; 46:79.",
"     </a>",
"    </li>",
"    <li>",
"     Northern JL, Downs MP. Hearing in children, 4th ed, Williams and Wilkins, Baltimore 1991.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/5\">",
"      Erenberg A, Lemons J, Sia C, et al. Newborn and infant hearing loss: detection and intervention.American Academy of Pediatrics. Task Force on Newborn and Infant Hearing, 1998- 1999. Pediatrics 1999; 103:527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/6\">",
"      Robinshaw HM. Early intervention for hearing impairment: differences in the timing of communicative and linguistic development. Br J Audiol 1995; 29:315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/7\">",
"      Robinshaw HM. The pattern of development from non-communicative behaviour to language by hearing impaired and hearing infants. Br J Audiol 1996; 30:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/8\">",
"      Roizen NJ. Etiology of hearing loss in children. Nongenetic causes. Pediatr Clin North Am 1999; 46:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/9\">",
"      Stewart JM, Downs MP. Congenital conductive hearing loss: the need for early identification and intervention. Pediatrics 1993; 91:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/10\">",
"      Jahrsdoerfer RA. Congenital atresia of the ear. Laryngoscope 1978; 88:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/11\">",
"      Teele DW, Klein JO, Rosner B. Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study. J Infect Dis 1989; 160:83.",
"     </a>",
"    </li>",
"    <li>",
"     Alper DM, Bluestone CD. Advanced therapy in otitis media, BC Decker Incorporated, Hamilton, Ontario 2004.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/13\">",
"      Klein JO. Otitis media. Clin Infect Dis 1994; 19:823.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/14\">",
"      Infante-Rivard C, Fern&aacute;ndez A. Otitis media in children: frequency, risk factors, and research avenues. Epidemiol Rev 1993; 15:444.",
"     </a>",
"    </li>",
"    <li>",
"     Bluestone CD, Klein JO. Intratemporal complications and sequelae of otitis media. In: Pediatric otolaryngology, Bluestone CD, Stool SE (Eds), WB Saunders, 1983. Vol 1.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/16\">",
"      Klausen O, M&oslash;ller P, Holmefjord A, et al. Lasting effects of otitis media with effusion on language skills and listening performance. Acta Otolaryngol Suppl 2000; 543:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/17\">",
"      Petinou KC, Schwartz RG, Gravel JS, Raphael LJ. A preliminary account of phonological and morphophonological perception in young children with and without otitis media. Int J Lang Commun Disord 2001; 36:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/18\">",
"      Bennett KE, Haggard MP, Silva PA, Stewart IA. Behaviour and developmental effects of otitis media with effusion into the teens. Arch Dis Child 2001; 85:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/19\">",
"      Paradise JL, Feldman HM, Campbell TF, et al. Effect of early or delayed insertion of tympanostomy tubes for persistent otitis media on developmental outcomes at the age of three years. N Engl J Med 2001; 344:1179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/20\">",
"      Paradise JL, Feldman HM, Campbell TF, et al. Early versus delayed insertion of tympanostomy tubes for persistent otitis media: developmental outcomes at the age of three years in relation to prerandomization illness patterns and hearing levels. Pediatr Infect Dis J 2003; 22:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/21\">",
"      Paradise JL, Dollaghan CA, Campbell TF, et al. Otitis media and tympanostomy tube insertion during the first three years of life: developmental outcomes at the age of four years. Pediatrics 2003; 112:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/22\">",
"      Paradise JL, Campbell TF, Dollaghan CA, et al. Developmental outcomes after early or delayed insertion of tympanostomy tubes. N Engl J Med 2005; 353:576.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/23\">",
"      Paradise JL, Feldman HM, Campbell TF, et al. Tympanostomy tubes and developmental outcomes at 9 to 11 years of age. N Engl J Med 2007; 356:248.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/24\">",
"      Cannon CR, Jahrsdoerfer RA. Temporal bone fractures. Review of 90 cases. Arch Otolaryngol 1983; 109:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/25\">",
"      Wasserman EE, Nelson K, Rose NR, et al. Maternal thyroid autoantibodies during the third trimester and hearing deficits in children: an epidemiologic assessment. Am J Epidemiol 2008; 167:701.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/26\">",
"      Weller TH. The cytomegaloviruses: ubiquitous agents with protean clinical manifestations. I. N Engl J Med 1971; 285:203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/27\">",
"      Ogawa H, Suzutani T, Baba Y, et al. Etiology of severe sensorineural hearing loss in children: independent impact of congenital cytomegalovirus infection and GJB2 mutations. J Infect Dis 2007; 195:782.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/28\">",
"      Kimani JW, Buchman CA, Booker JK, et al. Sensorineural hearing loss in a pediatric population: association of congenital cytomegalovirus infection with intracranial abnormalities. Arch Otolaryngol Head Neck Surg 2010; 136:999.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/29\">",
"      Misono S, Sie KC, Weiss NS, et al. Congenital cytomegalovirus infection in pediatric hearing loss. Arch Otolaryngol Head Neck Surg 2011; 137:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/30\">",
"      Ramsay ME, Miller E, Peckham CS. Outcome of confirmed symptomatic congenital cytomegalovirus infection. Arch Dis Child 1991; 66:1068.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/31\">",
"      Fowler KB, McCollister FP, Dahle AJ, et al. Progressive and fluctuating sensorineural hearing loss in children with asymptomatic congenital cytomegalovirus infection. J Pediatr 1997; 130:624.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/32\">",
"      McGee T, Wolters C, Stein L, et al. Absence of sensorineural hearing loss in treated infants and children with congenital toxoplasmosis. Otolaryngol Head Neck Surg 1992; 106:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/33\">",
"      Strasnick B, Jacobson JT. Teratogenic hearing loss. J Am Acad Audiol 1995; 6:28.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/34\">",
"      Centers for Disease Control. Rubella prevention. MMWR 1990; 39(RR15):1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/35\">",
"      Stamos JK, Rowley AH. Timely diagnosis of congenital infections. Pediatr Clin North Am 1994; 41:1017.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/36\">",
"      Wilkins A, Prabhu SP, Huang L, et al. Frequent association of cochlear nerve canal stenosis with pediatric sensorineural hearing loss. Arch Otolaryngol Head Neck Surg 2012; 138:383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/37\">",
"      Tomaski SM, Grundfast KM. A stepwise approach to the diagnosis and treatment of hereditary hearing loss. Pediatr Clin North Am 1999; 46:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/38\">",
"      Cohn ES, Kelley PM, Fowler TW, et al. Clinical studies of families with hearing loss attributable to mutations in the connexin 26 gene (GJB2/DFNB1). Pediatrics 1999; 103:546.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/39\">",
"      Grundfast KM, Atwood JL, Chuong D. Genetics and molecular biology of deafness. Otolaryngol Clin North Am 1999; 32:1067.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/40\">",
"      Skvorak Giersch AB, Morton CC. Genetic causes of nonsyndromic hearing loss. Curr Opin Pediatr 1999; 11:551.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/41\">",
"      Smith RJ, Van Camp G. Non-syndromic hearing impairment: gene linkage and cloning. Int J Pediatr Otorhinolaryngol 1999; 49 Suppl 1:S159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/42\">",
"      Zelante L, Gasparini P, Estivill X, et al. Connexin26 mutations associated with the most common form of non-syndromic neurosensory autosomal recessive deafness (DFNB1) in Mediterraneans. Hum Mol Genet 1997; 6:1605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/43\">",
"      del Castillo I, Villamar M, Moreno-Pelayo MA, et al. A deletion involving the connexin 30 gene in nonsyndromic hearing impairment. N Engl J Med 2002; 346:243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/44\">",
"      Schraders M, Oostrik J, Huygen PL, et al. Mutations in PTPRQ are a cause of autosomal-recessive nonsyndromic hearing impairment DFNB84 and associated with vestibular dysfunction. Am J Hum Genet 2010; 86:604.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/45\">",
"      Mochizuki T, Lemmink HH, Mariyama M, et al. Identification of mutations in the alpha 3(IV) and alpha 4(IV) collagen genes in autosomal recessive Alport syndrome. Nat Genet 1994; 8:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/46\">",
"      Mhatre AN, Lalwani AK. Molecular genetics of deafness. Otolaryngol Clin North Am 1996; 29:421.",
"     </a>",
"    </li>",
"    <li>",
"     Van Camp G, Smith RJ. Hereditary hearing loss homepage. webhost.ua.ac.be/hhh/ (Accessed on January 18, 2006).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/48\">",
"      Kenna MA, Wu BL, Cotanche DA, et al. Connexin 26 studies in patients with sensorineural hearing loss. Arch Otolaryngol Head Neck Surg 2001; 127:1037.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/49\">",
"      Frei K, Ramsebner R, Lucas T, et al. GJB2 mutations in hearing impairment: identification of a broad clinical spectrum for improved genetic counseling. Laryngoscope 2005; 115:461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/50\">",
"      Denoyelle F, Weil D, Maw MA, et al. Prelingual deafness: high prevalence of a 30delG mutation in the connexin 26 gene. Hum Mol Genet 1997; 6:2173.",
"     </a>",
"    </li>",
"    <li>",
"     Rabionet R, Gasparini P, Estivill X. Connexins and deafness homepage. davinci.crg.es/deafness/ (Accessed on January 18, 2006).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/52\">",
"      Duggal P, Vesely MR, Wattanasirichaigoon D, et al. Mutation of the gene for IsK associated with both Jervell and Lange-Nielsen and Romano-Ward forms of Long-QT syndrome. Circulation 1998; 97:142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/53\">",
"      Zarchi O, Attias J, Raveh E, et al. A comparative study of hearing loss in two microdeletion syndromes: velocardiofacial (22q11.2 deletion) and Williams (7q11.23 deletion) syndromes. J Pediatr 2011; 158:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/54\">",
"      Pfister MH, Apaydin F, Turan O, et al. A second family with nonsyndromic sensorineural hearing loss linked to Xp21.2: refinement of the DFN4 locus within DMD. Genomics 1998; 53:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/55\">",
"      Van Naarden K, Decoufl&eacute; P. Relative and attributable risks for moderate to profound bilateral sensorineural hearing impairment associated with lower birth weight in children 3 to 10 years old. Pediatrics 1999; 104:905.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/56\">",
"      Douek E, Dodson HC, Bannister LH, et al. Effects of incubator noise on the cochlea of the newborn. Lancet 1976; 2:1110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/57\">",
"      Razi MS, Das VK. Effects of adverse perinatal events on hearing. Int J Pediatr Otorhinolaryngol 1994; 30:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/58\">",
"      Cristobal R, Oghalai JS. Hearing loss in children with very low birth weight: current review of epidemiology and pathophysiology. Arch Dis Child Fetal Neonatal Ed 2008; 93:F462.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/59\">",
"      Ehrenhaft PM, Wagner JL, Herdman RC. Changing prognosis for very low birth weight infants. Obstet Gynecol 1989; 74:528.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/60\">",
"      Mervis CA, Decoufl&eacute; P, Murphy CC, Yeargin-Allsopp M. Low birthweight and the risk for mental retardation later in childhood. Paediatr Perinat Epidemiol 1995; 9:455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/61\">",
"      de Vries LS, Lary S, Dubowitz LM. Relationship of serum bilirubin levels to ototoxicity and deafness in high-risk low-birth-weight infants. Pediatrics 1985; 76:351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/62\">",
"      Fortnum HM. Hearing impairment after bacterial meningitis: a review. Arch Dis Child 1992; 67:1128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/63\">",
"      Fortnum H, Davis A. Epidemiology of permanent childhood hearing impairment in Trent Region, 1985-1993. Br J Audiol 1997; 31:409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/64\">",
"      Dodge PR, Davis H, Feigin RD, et al. Prospective evaluation of hearing impairment as a sequela of acute bacterial meningitis. N Engl J Med 1984; 311:869.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/65\">",
"      Richardson MP, Reid A, Tarlow MJ, Rudd PT. Hearing loss during bacterial meningitis. Arch Dis Child 1997; 76:134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/66\">",
"      Kaplan SL, Catlin FI, Weaver T, Feigin RD. Onset of hearing loss in children with bacterial meningitis. Pediatrics 1984; 73:575.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/67\">",
"      Vienny H, Despland PA, L&uuml;tschg J, et al. Early diagnosis and evolution of deafness in childhood bacterial meningitis: a study using brainstem auditory evoked potentials. Pediatrics 1984; 73:579.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/68\">",
"      Kaplan SL, Woods CR. Neurologic complications of bacterial meningitis in children. Curr Clin Top Infect Dis 1992; 12:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/69\">",
"      Kopelovich JC, Germiller JA, Laury AM, et al. Early prediction of postmeningitic hearing loss in children using magnetic resonance imaging. Arch Otolaryngol Head Neck Surg 2011; 137:441.",
"     </a>",
"    </li>",
"    <li>",
"     Bendush CL. Ototoxicity: Clinical considerations and comparative information. In: The aminoglycosides: Microbiology, clinical use and toxicology, Marcel Dekker, New York 1982. p.453.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/71\">",
"      Robertson CM, Tyebkhan JM, Peliowski A, et al. Ototoxic drugs and sensorineural hearing loss following severe neonatal respiratory failure. Acta Paediatr 2006; 95:214.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/72\">",
"      Prezant TR, Agapian JV, Bohlman MC, et al. Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness. Nat Genet 1993; 4:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/73\">",
"      Casano RA, Johnson DF, Bykhovskaya Y, et al. Inherited susceptibility to aminoglycoside ototoxicity: genetic heterogeneity and clinical implications. Am J Otolaryngol 1999; 20:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/74\">",
"      Stavroulaki P, Apostolopoulos N, Dinopoulou D, et al. Otoacoustic emissions--an approach for monitoring aminoglycoside induced ototoxicity in children. Int J Pediatr Otorhinolaryngol 1999; 50:177.",
"     </a>",
"    </li>",
"    <li>",
"     Gerber SE. The handbook of pediatric audiology, Gallaudet University Press, Washington, DC 1996.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/76\">",
"      Berg AL, Spitzer JB, Garvin JH Jr. Ototoxic impact of cisplatin in pediatric oncology patients. Laryngoscope 1999; 109:1806.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/77\">",
"      Gallagher KL, Jones JK. Furosemide-induced ototoxicity. Ann Intern Med 1979; 91:744.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/78\">",
"      Smith RJ, Bale JF Jr, White KR. Sensorineural hearing loss in children. Lancet 2005; 365:879.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/79\">",
"      Niskar AS, Kieszak SM, Holmes AE, et al. Estimated prevalence of noise-induced hearing threshold shifts among children 6 to 19 years of age: the Third National Health and Nutrition Examination Survey, 1988-1994, United States. Pediatrics 2001; 108:40.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/80\">",
"      Prasher D. New strategies for prevention and treatment of noise-induced hearing loss. Lancet 1998; 352:1240.",
"     </a>",
"    </li>",
"    <li>",
"     Shih L. Cochlear hearing loss in neurotology. In: Neurotology, Jackler R, Brackman DE (Eds), Mosby, St. Louis 1994. p.619.",
"    </li>",
"    <li>",
"     Recommendations for a noise standard. In: Occupational Noise Exposure: NIOSH Publication Number 98-126/CDC/NIOSH. www.cdc.gov/niosh/docs/98-126/chap1.html (Accessed on December 19, 2006).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/83\">",
"      Fligor BJ, Cox LC. Output levels of commercially available portable compact disc players and the potential risk to hearing. Ear Hear 2004; 25:513.",
"     </a>",
"    </li>",
"    <li>",
"     Portnuff C, Fligor B. \"Sound output levels of the iPod and other MP3 players. Is there potential risk to hearing?\" Presented at Noise-Induced Hearing Loss in Children at Work and Play Conference, Cincinnati, OH, October 19-20, 2006. www.hearingconservation.org/docs/virtualPressRoom/portnuff.htm (Accessed on December 19, 2006).",
"    </li>",
"    <li>",
"     Jackler RK. Acoustic neuroma. In: Neurotology, Jackler R, Brackman DE (Eds), Mosby, St. Louis 1994. p.729.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/86\">",
"      Prasher D. Heavy metals and noise exposure: health effects. Noise Health 2009; 11:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/87\">",
"      Shargorodsky J, Curhan SG, Henderson E, et al. Heavy metals exposure and hearing loss in US adolescents. Arch Otolaryngol Head Neck Surg 2011; 137:1183.",
"     </a>",
"    </li>",
"    <li>",
"     Hall JW III, Mueller HG III. Audiologists' desk reference, Singular Publishing Group, San Diego 1997. Vol 1.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/89\">",
"      Jerger J, Musiek F. Report of the Consensus Conference on the Diagnosis of Auditory Processing Disorders in School-Aged Children. J Am Acad Audiol 2000; 11:467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/90\">",
"      Varga R, Kelley PM, Keats BJ, et al. Non-syndromic recessive auditory neuropathy is the result of mutations in the otoferlin (OTOF) gene. J Med Genet 2003; 40:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/38/19050/abstract/91\">",
"      Deltenre P, Mansbach AL, Bozet C, et al. Auditory neuropathy with preserved cochlear microphonics and secondary loss of otoacoustic emissions. Audiology 1999; 38:187.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6308 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-203.80.222.8-8F853297CB-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_38_19050=[""].join("\n");
var outline_f18_38_19050=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H3545487\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ANATOMY AND PHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CLASSIFICATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CONDUCTIVE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Outer ear",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Congenital",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1687404\">",
"      - Obstruction",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Infection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Trauma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Middle ear",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Congenital",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Infection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - TM perforation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Trauma",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      SENSORINEURAL",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Congenital",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Infection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Malformations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Perilymph fistula",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Hereditary",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Autosomal recessive",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Autosomal dominant",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - X-linked",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Mitochondrial",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Acquired SNHL",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      - Prematurity",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      - Hyperbilirubinemia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      - Infection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      - Ototoxic drugs",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      - Noise exposure",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      - Trauma",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      - Tumors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H28805698\">",
"      - Heavy metals",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1687470\">",
"      CENTRAL",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3545487\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ALLRG/6308\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/6308|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?27/60/28610\" title=\"diagnostic image 1\">",
"      Transverse temporal fracture",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/6308|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?33/19/34103\" title=\"figure 1\">",
"      External ear anatomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?29/43/30387\" title=\"figure 2\">",
"      Audiogram noise hearing loss",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/6308|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?15/32/15874\" title=\"picture 1\">",
"      Traumatic perforation of TM",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?2/27/2481\" title=\"picture 2\">",
"      Otoscopic view of right ear with large congenital cholesteatoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?33/18/34084\" title=\"picture 3\">",
"      Waardenburg syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/6308|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?4/62/5101\" title=\"table 1\">",
"      Causes of hearing loss",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?12/21/12638\" title=\"table 2\">",
"      Syndromes with hearing loss",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/60/29642?source=related_link\">",
"      Acute otitis media in children: Epidemiology, microbiology, clinical manifestations, and complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/56/905?source=related_link\">",
"      Approach to the metabolic myopathies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/29/11738?source=related_link\">",
"      Care of the neonatal intensive care unit graduate",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/51/42808?source=related_link\">",
"      Cholesteatoma in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/6/7274?source=related_link\">",
"      Clinical features and diagnosis of the mucopolysaccharidoses",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/9/2202?source=related_link\">",
"      Clinical features of congenital long QT syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/63/25593?source=related_link\">",
"      Clinical manifestations of unconjugated hyperbilirubinemia in term and late preterm infants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/33/36377?source=related_link\">",
"      Clinical manifestations, diagnosis and treatment of hereditary nephritis (Alport syndrome)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/45/24280?source=related_link\">",
"      Congenital and acquired goiter in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/49/12055?source=related_link\">",
"      Congenital anomalies of the ear",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/59/1977?source=related_link\">",
"      Congenital anomalies of the jaw, mouth, oral cavity, and pharynx",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/49/10010?source=related_link\">",
"      Congenital rubella syndrome: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/31/17914?source=related_link\">",
"      Congenital syphilis: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/12/43208?source=related_link\">",
"      Congenital toxoplasmosis: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/18/8487?source=related_link\">",
"      Craniosynostosis syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/51/36664?source=related_link\">",
"      Cytomegalovirus infection and disease in newborns, infants, children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/57/21399?source=related_link\">",
"      Etiology of speech and language disorders in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/29/5593?source=related_link\">",
"      Evaluation and management of middle ear trauma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/19/44344?source=related_link\">",
"      Evaluation of hearing impairment in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/62/32743?source=related_link\">",
"      External otitis: Pathogenesis, clinical features, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/0/28681?source=related_link\">",
"      Genetics of congenital and acquired long QT syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/5/24663?source=related_link\">",
"      Genetics, pathogenesis, and pathology of hereditary nephritis (Alport syndrome)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/50/36650?source=related_link\">",
"      Neurofibromatosis type 1 (von Recklinghausen's disease)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/14/20712?source=related_link\">",
"      Neurofibromatosis type 2",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/58/31656?source=related_link\">",
"      Neurologic complications of bacterial meningitis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/23/37242?source=related_link\">",
"      Neurologic complications of platinum-based chemotherapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/9/38040?source=related_link\">",
"      Osteogenesis imperfecta: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/40/22153?source=related_link\">",
"      Otitis media with effusion (serous otitis media) in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/24/28041?source=related_link\">",
"      Overview of TORCH infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/56/3978?source=related_link\">",
"      Overview of tympanostomy tube placement and medical care of children with tympanostomy tubes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/41/18072?source=related_link\">",
"      Pathogenesis and prevention of aminoglycoside nephrotoxicity and ototoxicity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/43/10935?source=related_link\">",
"      Renal hypoplasia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/27/19896?source=related_link\">",
"      Retinitis pigmentosa: Clinical presentation and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/13/43225?source=related_link\">",
"      Screening tests in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/13/27865?source=related_link\">",
"      Screening the newborn for hearing loss",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/24/13704?source=related_link\">",
"      Skull fractures in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/15/250?source=related_link\">",
"      Syndromes with craniofacial abnormalities",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/0/24586?source=related_link\">",
"      The genodermatoses",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/35/38458?source=related_link\">",
"      Treatment and prognosis of acute bacterial meningitis in children older than one month of age",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/14/29927?source=related_link\">",
"      Treatment of hearing impairment in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/18/40232?source=related_link\">",
"      Vestibular schwannoma (acoustic neuroma)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f18_38_19051="Regimens for toxoplasmosis";
var content_f18_38_19051=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F75331&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F75331&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Standard treatment regimens for toxoplasmosis in patients with AIDS",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Drug",
"       </td>",
"       <td class=\"subtitle1\">",
"        Dose/Route",
"       </td>",
"       <td class=\"subtitle1\">",
"        Adverse reactions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Pyrimethamine",
"        <strong>",
"         PLUS",
"        </strong>",
"       </td>",
"       <td class=\"sublist_other_start\">",
"        Loading - 200 mg PO followed by 30-75 mg/day for three to six weeks",
"       </td>",
"       <td class=\"sublist_other_start\">",
"        Bone marrow suppression, vomiting, diarrhea, seizures, hematuria, dysrhythmias, rash",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Sulfadiazine",
"        <strong>",
"         OR",
"        </strong>",
"       </td>",
"       <td class=\"sublist_other\">",
"        1-1.5 grams every 6 hours PO for three to six weeks",
"       </td>",
"       <td class=\"sublist_other\">",
"        Bone marrow suppression, rash, nausea, nephrotoxicity, encephalopathy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Clindamycin",
"       </td>",
"       <td class=\"sublist_other\">",
"        1200 mg every 6 hours PO for 3 weeks, followed by 300 mg every 6 hours for 3 weeks",
"       </td>",
"       <td class=\"sublist_other\">",
"        Nausea, vomiting, diarrhea, rash, neutropenia, pseudomembranous colitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Leucovorin",
"       </td>",
"       <td>",
"        10-20 mg PO/IV/IM per day",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_38_19051=[""].join("\n");
var outline_f18_38_19051=null;
var title_f18_38_19052="Indications endometrial evaluat";
var content_f18_38_19052=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F58600&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F58600&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Women who should undergo evaluation for endometrial hyperplasia or endometrial cancer",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        <strong>",
"         Abnormal uterine bleeding",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <ul>",
"         <li>",
"          Postmenopausal women&nbsp;&ndash; Any uterine bleeding, regardless of volume (including spotting or staining). Further evaluation of a sonographic finding of an endometrial thickness &gt;4 mm (even if the patient has no uterine bleeding).",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <ul>",
"         <li>",
"          Age 45 years to menopause &ndash; Any abnormal uterine bleeding, including intermenstrual bleeding in women who are ovulatory. Abnormal uterine bleeding in any woman that is&nbsp;frequent (interval between the onset of bleeding episodes is less than 21 days), heavy (total volume of &gt;80 mL), or prolonged (longer than seven days).",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <ul>",
"         <li>",
"          Younger than 45 years &ndash; Abnormal uterine bleeding that is persistent, occurs in the setting of a history of unopposed estrogen exposure (obesity, chronic anovulation) or failed medical management of the bleeding, or in women at high risk of endometrial cancer (eg, tamoxifen therapy, Lynch syndrome).",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <ul>",
"         <li>",
"          In addition, endometrial neoplasia should be suspected in premenopausal women who are anovulatory and have prolonged periods of amenorrhea (six or more months).",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Cervical cytology results",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <ul>",
"         <li>",
"          Presence of atypical glandular cells (AGC)-endometrial.",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <ul>",
"         <li>",
"          Presence of AGC-all subcategories other than endometrial&nbsp;&ndash;&nbsp;If &ge;35 years-old&nbsp;OR at risk for endometrial cancer (risk factors or symptoms).",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <ul>",
"         <li>",
"          Presence of benign-appearing endometrial cells in women &ge;40 years of age who also have abnormal uterine bleeding or risk factors for endometrial cancer.",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         &nbsp;Other indications",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <ul>",
"         <li>",
"          &nbsp;Monitoring of women with endometrial pathology (eg, endometrial hyperplasia).",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <ul>",
"         <li>",
"          &nbsp;Screening in women at high risk of endometrial cancer (eg, Lynch syndrome).",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_38_19052=[""].join("\n");
var outline_f18_38_19052=null;
var title_f18_38_19053="Liver biopsy II - jaundice and weight loss";
var content_f18_38_19053=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F78587&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F78587&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Liver biopsy from a 60-year-old man with erythropoietic protophorphyria (high power, H&amp;E stain exposed to polarized light)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 286px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Note several red \"Maltese crosses\".",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Marshall M. Kaplan, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_38_19053=[""].join("\n");
var outline_f18_38_19053=null;
var title_f18_38_19054="Character photons a";
var content_f18_38_19054=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F72496&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F72496&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Depth dose curve for an unmodulated proton beam, 10 MeV photon radiation, and spread-out Bragg Peak (SOBP) proton radiation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 414px; height: 290px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The dose distribution of an unmodulated proton beam consists of a slowly rising dose, a rapid rise to a maximum (also known as the Bragg Peak), followed by a fall to near zero. As a result, a significant portion of the beam energy is deposited in a small volume. In contrast, the energy deposition of photon irradiation is dictated by the laws of exponential decay and is distributed over a larger volume. Because of the sharpness of the Bragg Peak, a single monoenergetic proton beam will only irradiate an area approximately the size of a pituitary gland. Irradiation of larger targets is achieved by superimposing proton beams of different energies. The end result of this superposition is known as the spread-out Bragg Peak (SOBP).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Massachusetts General Hospital.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_38_19054=[""].join("\n");
var outline_f18_38_19054=null;
var title_f18_38_19055="J curve diastolic HTN";
var content_f18_38_19055=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F73430&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F73430&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 534px\">",
"   <div class=\"ttl\">",
"    Lack of true J-shaped curve in diastolic pressure",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 514px; height: 441px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Age- and sex-adjusted mortality rates (per 1000 patient years, bars show the 95 percent confidence intervals) according to achieved diastolic pressure in active treatment and control groups in a meta-analysis of seven randomized clinical trials of hypertensive patients. The number of events is shown below each bar. Among treated patients, cardiovascular mortality initially falls at achieved diastolic pressures below 106 mmHg and then rises again at low diastolic pressures (upper right panel). However, a similar relationship is seen with noncardiovascular mortality (bottom right panel) and in the control groups (left panels). Thus, the increase in mortality at low systolic pressures probably reflects underlying poor health rather than an adverse effect of antihypertensive therapy.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Boutitie, F, Gueyffier, F, Pocock, S, et al, Ann Intern Med 2002; 136:438.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_38_19055=[""].join("\n");
var outline_f18_38_19055=null;
